id	sid	tid	token	lemma	pos
cord-271653-4q2olzx1	1	1	key	key	JJ
cord-271653-4q2olzx1	2	1	:	:	:
cord-271653-4q2olzx1	2	2	cord-271653	cord-271653	NNP
cord-271653-4q2olzx1	2	3	-	-	HYPH
cord-271653-4q2olzx1	2	4	4q2olzx1	4q2olzx1	CD
cord-271653-4q2olzx1	2	5	authors	author	NNS
cord-271653-4q2olzx1	2	6	:	:	:
cord-271653-4q2olzx1	2	7	Libby	Libby	NNP
cord-271653-4q2olzx1	2	8	,	,	,
cord-271653-4q2olzx1	2	9	Peter	Peter	NNP
cord-271653-4q2olzx1	2	10	title	title	NN
cord-271653-4q2olzx1	2	11	:	:	:
cord-271653-4q2olzx1	2	12	The	the	DT
cord-271653-4q2olzx1	2	13	Heart	heart	NN
cord-271653-4q2olzx1	2	14	in	in	IN
cord-271653-4q2olzx1	2	15	COVID19	covid19	NN
cord-271653-4q2olzx1	2	16	:	:	:
cord-271653-4q2olzx1	2	17	Primary	Primary	NNP
cord-271653-4q2olzx1	2	18	Target	Target	NNP
cord-271653-4q2olzx1	2	19	or	or	CC
cord-271653-4q2olzx1	2	20	Secondary	secondary	JJ
cord-271653-4q2olzx1	2	21	Bystander	Bystander	NNP
cord-271653-4q2olzx1	2	22	?	?	.
cord-271653-4q2olzx1	3	1	date	date	NN
cord-271653-4q2olzx1	3	2	:	:	:
cord-271653-4q2olzx1	3	3	2020	2020	CD
cord-271653-4q2olzx1	3	4	-	-	HYPH
cord-271653-4q2olzx1	3	5	04	04	CD
cord-271653-4q2olzx1	3	6	-	-	SYM
cord-271653-4q2olzx1	3	7	10	10	CD
cord-271653-4q2olzx1	3	8	journal	journal	NN
cord-271653-4q2olzx1	3	9	:	:	:
cord-271653-4q2olzx1	3	10	JACC	JACC	NNP
cord-271653-4q2olzx1	3	11	Basic	Basic	NNP
cord-271653-4q2olzx1	3	12	Transl	Transl	NNP
cord-271653-4q2olzx1	4	1	Sci	Sci	NNP
cord-271653-4q2olzx1	4	2	DOI	DOI	NNP
cord-271653-4q2olzx1	4	3	:	:	:
cord-271653-4q2olzx1	4	4	10.1016	10.1016	CD
cord-271653-4q2olzx1	4	5	/	/	SYM
cord-271653-4q2olzx1	4	6	j.jacbts.2020.04.001	j.jacbts.2020.04.001	XX
cord-271653-4q2olzx1	4	7	sha	sha	NNP
cord-271653-4q2olzx1	4	8	:	:	:
cord-271653-4q2olzx1	4	9	e6eefd34cd7466463ab20f15d56ff5ef6e9a7bcc	e6eefd34cd7466463ab20f15d56ff5ef6e9a7bcc	NNP
cord-271653-4q2olzx1	4	10	doc_id	doc_id	NNPS
cord-271653-4q2olzx1	5	1	:	:	:
cord-271653-4q2olzx1	5	2	271653	271653	CD
cord-271653-4q2olzx1	5	3	cord_uid	cord_uid	NNS
cord-271653-4q2olzx1	5	4	:	:	:
cord-271653-4q2olzx1	6	1	4q2olzx1	4q2olzx1	CD
cord-271653-4q2olzx1	7	1	Summary	summary	NN
cord-271653-4q2olzx1	7	2	:	:	:
cord-271653-4q2olzx1	8	1	In	in	IN
cord-271653-4q2olzx1	8	2	the	the	DT
cord-271653-4q2olzx1	8	3	throes	throe	NNS
cord-271653-4q2olzx1	8	4	of	of	IN
cord-271653-4q2olzx1	8	5	the	the	DT
cord-271653-4q2olzx1	8	6	current	current	JJ
cord-271653-4q2olzx1	8	7	COVID-19	COVID-19	NNP
cord-271653-4q2olzx1	8	8	pandemic	pandemic	NN
cord-271653-4q2olzx1	8	9	,	,	,
cord-271653-4q2olzx1	8	10	interest	interest	NN
cord-271653-4q2olzx1	8	11	has	have	VBZ
cord-271653-4q2olzx1	8	12	burgeoned	burgeon	VBN
cord-271653-4q2olzx1	8	13	in	in	IN
cord-271653-4q2olzx1	8	14	the	the	DT
cord-271653-4q2olzx1	8	15	cardiovascular	cardiovascular	JJ
cord-271653-4q2olzx1	8	16	complications	complication	NNS
cord-271653-4q2olzx1	8	17	of	of	IN
cord-271653-4q2olzx1	8	18	this	this	DT
cord-271653-4q2olzx1	8	19	virulent	virulent	JJ
cord-271653-4q2olzx1	8	20	viral	viral	JJ
cord-271653-4q2olzx1	8	21	infection	infection	NN
cord-271653-4q2olzx1	8	22	.	.	.
cord-271653-4q2olzx1	9	1	As	as	IN
cord-271653-4q2olzx1	9	2	troponin	troponin	JJ
cord-271653-4q2olzx1	9	3	,	,	,
cord-271653-4q2olzx1	9	4	a	a	DT
cord-271653-4q2olzx1	9	5	biomarker	biomarker	NN
cord-271653-4q2olzx1	9	6	of	of	IN
cord-271653-4q2olzx1	9	7	cardiac	cardiac	JJ
cord-271653-4q2olzx1	9	8	injury	injury	NN
cord-271653-4q2olzx1	9	9	,	,	,
cord-271653-4q2olzx1	9	10	often	often	RB
cord-271653-4q2olzx1	9	11	rises	rise	VBZ
cord-271653-4q2olzx1	9	12	in	in	IN
cord-271653-4q2olzx1	9	13	hospitalized	hospitalize	VBN
cord-271653-4q2olzx1	9	14	patients	patient	NNS
cord-271653-4q2olzx1	9	15	,	,	,
cord-271653-4q2olzx1	9	16	its	-PRON-	PRP$
cord-271653-4q2olzx1	9	17	interpretation	interpretation	NN
cord-271653-4q2olzx1	9	18	and	and	CC
cord-271653-4q2olzx1	9	19	actionability	actionability	NN
cord-271653-4q2olzx1	9	20	require	require	VBP
cord-271653-4q2olzx1	9	21	careful	careful	JJ
cord-271653-4q2olzx1	9	22	consideration	consideration	NN
cord-271653-4q2olzx1	9	23	.	.	.
cord-271653-4q2olzx1	10	1	Fulminant	Fulminant	NNP
cord-271653-4q2olzx1	10	2	myocarditis	myocarditis	NN
cord-271653-4q2olzx1	10	3	due	due	IN
cord-271653-4q2olzx1	10	4	to	to	IN
cord-271653-4q2olzx1	10	5	direct	direct	JJ
cord-271653-4q2olzx1	10	6	viral	viral	JJ
cord-271653-4q2olzx1	10	7	infection	infection	NN
cord-271653-4q2olzx1	10	8	can	can	MD
cord-271653-4q2olzx1	10	9	certainly	certainly	RB
cord-271653-4q2olzx1	10	10	occur	occur	VB
cord-271653-4q2olzx1	10	11	,	,	,
cord-271653-4q2olzx1	10	12	but	but	CC
cord-271653-4q2olzx1	10	13	patients	patient	NNS
cord-271653-4q2olzx1	10	14	with	with	IN
cord-271653-4q2olzx1	10	15	increased	increase	VBN
cord-271653-4q2olzx1	10	16	oxygen	oxygen	NN
cord-271653-4q2olzx1	10	17	demands	demand	NNS
cord-271653-4q2olzx1	10	18	due	due	JJ
cord-271653-4q2olzx1	10	19	to	to	IN
cord-271653-4q2olzx1	10	20	tachycardia	tachycardia	NN
cord-271653-4q2olzx1	10	21	and	and	CC
cord-271653-4q2olzx1	10	22	fever	fever	NN
cord-271653-4q2olzx1	10	23	,	,	,
cord-271653-4q2olzx1	10	24	and	and	CC
cord-271653-4q2olzx1	10	25	reduced	reduce	VBN
cord-271653-4q2olzx1	10	26	oxygen	oxygen	NN
cord-271653-4q2olzx1	10	27	delivery	delivery	NN
cord-271653-4q2olzx1	10	28	due	due	JJ
cord-271653-4q2olzx1	10	29	to	to	IN
cord-271653-4q2olzx1	10	30	hypotension	hypotension	NN
cord-271653-4q2olzx1	10	31	and	and	CC
cord-271653-4q2olzx1	10	32	hypoxemia	hypoxemia	NN
cord-271653-4q2olzx1	10	33	can	can	MD
cord-271653-4q2olzx1	10	34	cause	cause	VB
cord-271653-4q2olzx1	10	35	myocardial	myocardial	JJ
cord-271653-4q2olzx1	10	36	injury	injury	NN
cord-271653-4q2olzx1	10	37	indirectly	indirectly	RB
cord-271653-4q2olzx1	10	38	.	.	.
cord-271653-4q2olzx1	11	1	Cytokines	cytokine	NNS
cord-271653-4q2olzx1	11	2	released	release	VBN
cord-271653-4q2olzx1	11	3	during	during	IN
cord-271653-4q2olzx1	11	4	the	the	DT
cord-271653-4q2olzx1	11	5	acute	acute	JJ
cord-271653-4q2olzx1	11	6	infection	infection	NN
cord-271653-4q2olzx1	11	7	can	can	MD
cord-271653-4q2olzx1	11	8	elicit	elicit	VB
cord-271653-4q2olzx1	11	9	activation	activation	NN
cord-271653-4q2olzx1	11	10	of	of	IN
cord-271653-4q2olzx1	11	11	cells	cell	NNS
cord-271653-4q2olzx1	11	12	within	within	IN
cord-271653-4q2olzx1	11	13	pre	pre	JJ
cord-271653-4q2olzx1	11	14	-	-	JJ
cord-271653-4q2olzx1	11	15	existing	existing	JJ
cord-271653-4q2olzx1	11	16	atherosclerotic	atherosclerotic	JJ
cord-271653-4q2olzx1	11	17	lesions	lesion	NNS
cord-271653-4q2olzx1	11	18	,	,	,
cord-271653-4q2olzx1	11	19	augmenting	augment	VBG
cord-271653-4q2olzx1	11	20	thrombotic	thrombotic	JJ
cord-271653-4q2olzx1	11	21	risk	risk	NN
cord-271653-4q2olzx1	11	22	and	and	CC
cord-271653-4q2olzx1	11	23	risk	risk	NN
cord-271653-4q2olzx1	11	24	of	of	IN
cord-271653-4q2olzx1	11	25	ischemic	ischemic	JJ
cord-271653-4q2olzx1	11	26	syndromes	syndrome	NNS
cord-271653-4q2olzx1	11	27	.	.	.
cord-271653-4q2olzx1	12	1	Moreover	moreover	RB
cord-271653-4q2olzx1	12	2	,	,	,
cord-271653-4q2olzx1	12	3	microvascular	microvascular	JJ
cord-271653-4q2olzx1	12	4	activation	activation	NN
cord-271653-4q2olzx1	12	5	by	by	IN
cord-271653-4q2olzx1	12	6	cytokines	cytokine	NNS
cord-271653-4q2olzx1	12	7	can	can	MD
cord-271653-4q2olzx1	12	8	cause	cause	VB
cord-271653-4q2olzx1	12	9	not	not	RB
cord-271653-4q2olzx1	12	10	only	only	RB
cord-271653-4q2olzx1	12	11	myocardial	myocardial	JJ
cord-271653-4q2olzx1	12	12	injury	injury	NN
cord-271653-4q2olzx1	12	13	but	but	CC
cord-271653-4q2olzx1	12	14	harm	harm	NN
cord-271653-4q2olzx1	12	15	other	other	JJ
cord-271653-4q2olzx1	12	16	organ	organ	NN
cord-271653-4q2olzx1	12	17	systems	system	NNS
cord-271653-4q2olzx1	12	18	commonly	commonly	RB
cord-271653-4q2olzx1	12	19	involved	involve	VBN
cord-271653-4q2olzx1	12	20	in	in	IN
cord-271653-4q2olzx1	12	21	COVID-19	covid-19	JJ
cord-271653-4q2olzx1	12	22	infections	infection	NNS
cord-271653-4q2olzx1	12	23	including	include	VBG
cord-271653-4q2olzx1	12	24	the	the	DT
cord-271653-4q2olzx1	12	25	kidneys	kidney	NNS
cord-271653-4q2olzx1	12	26	.	.	.
cord-271653-4q2olzx1	13	1	Dealing	deal	VBG
cord-271653-4q2olzx1	13	2	with	with	IN
cord-271653-4q2olzx1	13	3	the	the	DT
cord-271653-4q2olzx1	13	4	immense	immense	JJ
cord-271653-4q2olzx1	13	5	challenge	challenge	NN
cord-271653-4q2olzx1	13	6	of	of	IN
cord-271653-4q2olzx1	13	7	COVID-19	COVID-19	NNP
cord-271653-4q2olzx1	13	8	disease	disease	NN
cord-271653-4q2olzx1	13	9	,	,	,
cord-271653-4q2olzx1	13	10	confronted	confront	VBN
cord-271653-4q2olzx1	13	11	with	with	IN
cord-271653-4q2olzx1	13	12	severely	severely	RB
cord-271653-4q2olzx1	13	13	ill	ill	JJ
cord-271653-4q2olzx1	13	14	patients	patient	NNS
cord-271653-4q2olzx1	13	15	in	in	IN
cord-271653-4q2olzx1	13	16	dire	dire	JJ
cord-271653-4q2olzx1	13	17	straits	strait	NNS
cord-271653-4q2olzx1	13	18	with	with	IN
cord-271653-4q2olzx1	13	19	virtually	virtually	RB
cord-271653-4q2olzx1	13	20	no	no	DT
cord-271653-4q2olzx1	13	21	rigorous	rigorous	JJ
cord-271653-4q2olzx1	13	22	evidence	evidence	NN
cord-271653-4q2olzx1	13	23	base	base	NN
cord-271653-4q2olzx1	13	24	to	to	TO
cord-271653-4q2olzx1	13	25	guide	guide	VB
cord-271653-4q2olzx1	13	26	our	-PRON-	PRP$
cord-271653-4q2olzx1	13	27	therapy	therapy	NN
cord-271653-4q2olzx1	13	28	,	,	,
cord-271653-4q2olzx1	13	29	we	-PRON-	PRP
cord-271653-4q2olzx1	13	30	must	must	MD
cord-271653-4q2olzx1	13	31	call	call	VB
cord-271653-4q2olzx1	13	32	upon	upon	IN
cord-271653-4q2olzx1	13	33	our	-PRON-	PRP$
cord-271653-4q2olzx1	13	34	clinical	clinical	JJ
cord-271653-4q2olzx1	13	35	skills	skill	NNS
cord-271653-4q2olzx1	13	36	and	and	CC
cord-271653-4q2olzx1	13	37	judgment	judgment	NN
cord-271653-4q2olzx1	13	38	.	.	.
cord-271653-4q2olzx1	14	1	These	these	DT
cord-271653-4q2olzx1	14	2	touchstones	touchstone	NNS
cord-271653-4q2olzx1	14	3	can	can	MD
cord-271653-4q2olzx1	14	4	help	help	VB
cord-271653-4q2olzx1	14	5	guide	guide	VB
cord-271653-4q2olzx1	14	6	us	-PRON-	PRP
cord-271653-4q2olzx1	14	7	in	in	IN
cord-271653-4q2olzx1	14	8	selecting	select	VBG
cord-271653-4q2olzx1	14	9	patients	patient	NNS
cord-271653-4q2olzx1	14	10	who	who	WP
cord-271653-4q2olzx1	14	11	might	may	MD
cord-271653-4q2olzx1	14	12	benefit	benefit	VB
cord-271653-4q2olzx1	14	13	from	from	IN
cord-271653-4q2olzx1	14	14	the	the	DT
cord-271653-4q2olzx1	14	15	advanced	advanced	JJ
cord-271653-4q2olzx1	14	16	imaging	imaging	NN
cord-271653-4q2olzx1	14	17	and	and	CC
cord-271653-4q2olzx1	14	18	invasive	invasive	JJ
cord-271653-4q2olzx1	14	19	procedures	procedure	NNS
cord-271653-4q2olzx1	14	20	that	that	WDT
cord-271653-4q2olzx1	14	21	present	present	VBP
cord-271653-4q2olzx1	14	22	enormous	enormous	JJ
cord-271653-4q2olzx1	14	23	logistical	logistical	JJ
cord-271653-4q2olzx1	14	24	challenges	challenge	NNS
cord-271653-4q2olzx1	14	25	in	in	IN
cord-271653-4q2olzx1	14	26	the	the	DT
cord-271653-4q2olzx1	14	27	current	current	JJ
cord-271653-4q2olzx1	14	28	context	context	NN
cord-271653-4q2olzx1	14	29	.	.	.
cord-271653-4q2olzx1	15	1	Lacking	lack	VBG
cord-271653-4q2olzx1	15	2	a	a	DT
cord-271653-4q2olzx1	15	3	robust	robust	JJ
cord-271653-4q2olzx1	15	4	evidence	evidence	NN
cord-271653-4q2olzx1	15	5	base	base	NN
cord-271653-4q2olzx1	15	6	,	,	,
cord-271653-4q2olzx1	15	7	pathophysiologic	pathophysiologic	NN
cord-271653-4q2olzx1	15	8	reasoning	reasoning	NN
cord-271653-4q2olzx1	15	9	can	can	MD
cord-271653-4q2olzx1	15	10	help	help	VB
cord-271653-4q2olzx1	15	11	guide	guide	VB
cord-271653-4q2olzx1	15	12	our	-PRON-	PRP$
cord-271653-4q2olzx1	15	13	choices	choice	NNS
cord-271653-4q2olzx1	15	14	of	of	IN
cord-271653-4q2olzx1	15	15	therapy	therapy	NN
cord-271653-4q2olzx1	15	16	for	for	IN
cord-271653-4q2olzx1	15	17	individual	individual	JJ
cord-271653-4q2olzx1	15	18	clinical	clinical	JJ
cord-271653-4q2olzx1	15	19	scenarios	scenario	NNS
cord-271653-4q2olzx1	15	20	.	.	.
cord-271653-4q2olzx1	16	1	We	-PRON-	PRP
cord-271653-4q2olzx1	16	2	must	must	MD
cord-271653-4q2olzx1	16	3	exercise	exercise	VB
cord-271653-4q2olzx1	16	4	caution	caution	NN
cord-271653-4q2olzx1	16	5	and	and	CC
cord-271653-4q2olzx1	16	6	extreme	extreme	JJ
cord-271653-4q2olzx1	16	7	humility	humility	NN
cord-271653-4q2olzx1	16	8	,	,	,
cord-271653-4q2olzx1	16	9	as	as	IN
cord-271653-4q2olzx1	16	10	often	often	RB
cord-271653-4q2olzx1	16	11	plausible	plausible	JJ
cord-271653-4q2olzx1	16	12	interventions	intervention	NNS
cord-271653-4q2olzx1	16	13	fail	fail	VBP
cord-271653-4q2olzx1	16	14	when	when	WRB
cord-271653-4q2olzx1	16	15	tested	test	VBN
cord-271653-4q2olzx1	16	16	rigorously	rigorously	RB
cord-271653-4q2olzx1	16	17	.	.	.
cord-271653-4q2olzx1	17	1	But	but	CC
cord-271653-4q2olzx1	17	2	act	act	VB
cord-271653-4q2olzx1	17	3	today	today	NN
cord-271653-4q2olzx1	17	4	we	-PRON-	PRP
cord-271653-4q2olzx1	17	5	must	must	MD
cord-271653-4q2olzx1	17	6	,	,	,
cord-271653-4q2olzx1	17	7	and	and	CC
cord-271653-4q2olzx1	17	8	understanding	understand	VBG
cord-271653-4q2olzx1	17	9	the	the	DT
cord-271653-4q2olzx1	17	10	multiplicity	multiplicity	NN
cord-271653-4q2olzx1	17	11	of	of	IN
cord-271653-4q2olzx1	17	12	mechanisms	mechanism	NNS
cord-271653-4q2olzx1	17	13	of	of	IN
cord-271653-4q2olzx1	17	14	myocardial	myocardial	JJ
cord-271653-4q2olzx1	17	15	injury	injury	NN
cord-271653-4q2olzx1	17	16	in	in	IN
cord-271653-4q2olzx1	17	17	COVID-19	COVID-19	NNP
cord-271653-4q2olzx1	17	18	infection	infection	NN
cord-271653-4q2olzx1	17	19	will	will	MD
cord-271653-4q2olzx1	17	20	help	help	VB
cord-271653-4q2olzx1	17	21	us	-PRON-	PRP
cord-271653-4q2olzx1	17	22	meet	meet	VB
cord-271653-4q2olzx1	17	23	our	-PRON-	PRP$
cord-271653-4q2olzx1	17	24	mission	mission	NN
cord-271653-4q2olzx1	17	25	unsupported	unsupported	JJ
cord-271653-4q2olzx1	17	26	by	by	IN
cord-271653-4q2olzx1	17	27	the	the	DT
cord-271653-4q2olzx1	17	28	comfort	comfort	NN
cord-271653-4q2olzx1	17	29	of	of	IN
cord-271653-4q2olzx1	17	30	strong	strong	JJ
cord-271653-4q2olzx1	17	31	data	datum	NNS
cord-271653-4q2olzx1	17	32	.	.	.
cord-271653-4q2olzx1	18	1	In	in	IN
cord-271653-4q2olzx1	18	2	the	the	DT
cord-271653-4q2olzx1	18	3	throes	throe	NNS
cord-271653-4q2olzx1	18	4	of	of	IN
cord-271653-4q2olzx1	18	5	the	the	DT
cord-271653-4q2olzx1	18	6	current	current	JJ
cord-271653-4q2olzx1	18	7	COVID-19	COVID-19	NNP
cord-271653-4q2olzx1	18	8	pandemic	pandemic	NN
cord-271653-4q2olzx1	18	9	,	,	,
cord-271653-4q2olzx1	18	10	interest	interest	NN
cord-271653-4q2olzx1	18	11	has	have	VBZ
cord-271653-4q2olzx1	18	12	burgeoned	burgeon	VBN
cord-271653-4q2olzx1	18	13	in	in	IN
cord-271653-4q2olzx1	18	14	the	the	DT
cord-271653-4q2olzx1	18	15	cardiovascular	cardiovascular	JJ
cord-271653-4q2olzx1	18	16	complications	complication	NNS
cord-271653-4q2olzx1	18	17	of	of	IN
cord-271653-4q2olzx1	18	18	this	this	DT
cord-271653-4q2olzx1	18	19	virulent	virulent	JJ
cord-271653-4q2olzx1	18	20	viral	viral	JJ
cord-271653-4q2olzx1	18	21	infection	infection	NN
cord-271653-4q2olzx1	18	22	.	.	.
cord-271653-4q2olzx1	19	1	As	as	IN
cord-271653-4q2olzx1	19	2	troponin	troponin	JJ
cord-271653-4q2olzx1	19	3	,	,	,
cord-271653-4q2olzx1	19	4	a	a	DT
cord-271653-4q2olzx1	19	5	biomarker	biomarker	NN
cord-271653-4q2olzx1	19	6	of	of	IN
cord-271653-4q2olzx1	19	7	cardiac	cardiac	JJ
cord-271653-4q2olzx1	19	8	injury	injury	NN
cord-271653-4q2olzx1	19	9	,	,	,
cord-271653-4q2olzx1	19	10	often	often	RB
cord-271653-4q2olzx1	19	11	rises	rise	VBZ
cord-271653-4q2olzx1	19	12	in	in	IN
cord-271653-4q2olzx1	19	13	hospitalized	hospitalize	VBN
cord-271653-4q2olzx1	19	14	patients	patient	NNS
cord-271653-4q2olzx1	19	15	,	,	,
cord-271653-4q2olzx1	19	16	its	-PRON-	PRP$
cord-271653-4q2olzx1	19	17	interpretation	interpretation	NN
cord-271653-4q2olzx1	19	18	and	and	CC
cord-271653-4q2olzx1	19	19	actionability	actionability	NN
cord-271653-4q2olzx1	19	20	require	require	VBP
cord-271653-4q2olzx1	19	21	careful	careful	JJ
cord-271653-4q2olzx1	19	22	consideration	consideration	NN
cord-271653-4q2olzx1	19	23	.	.	.
cord-271653-4q2olzx1	20	1	Fulminant	Fulminant	NNP
cord-271653-4q2olzx1	20	2	myocarditis	myocarditis	NN
cord-271653-4q2olzx1	20	3	due	due	IN
cord-271653-4q2olzx1	20	4	to	to	IN
cord-271653-4q2olzx1	20	5	direct	direct	JJ
cord-271653-4q2olzx1	20	6	viral	viral	JJ
cord-271653-4q2olzx1	20	7	infection	infection	NN
cord-271653-4q2olzx1	20	8	can	can	MD
cord-271653-4q2olzx1	20	9	certainly	certainly	RB
cord-271653-4q2olzx1	20	10	occur	occur	VB
cord-271653-4q2olzx1	20	11	,	,	,
cord-271653-4q2olzx1	20	12	but	but	CC
cord-271653-4q2olzx1	20	13	patients	patient	NNS
cord-271653-4q2olzx1	20	14	with	with	IN
cord-271653-4q2olzx1	20	15	increased	increase	VBN
cord-271653-4q2olzx1	20	16	oxygen	oxygen	NN
cord-271653-4q2olzx1	20	17	demands	demand	NNS
cord-271653-4q2olzx1	20	18	due	due	JJ
cord-271653-4q2olzx1	20	19	to	to	IN
cord-271653-4q2olzx1	20	20	tachycardia	tachycardia	NN
cord-271653-4q2olzx1	20	21	and	and	CC
cord-271653-4q2olzx1	20	22	fever	fever	NN
cord-271653-4q2olzx1	20	23	,	,	,
cord-271653-4q2olzx1	20	24	and	and	CC
cord-271653-4q2olzx1	20	25	reduced	reduce	VBN
cord-271653-4q2olzx1	20	26	oxygen	oxygen	NN
cord-271653-4q2olzx1	20	27	delivery	delivery	NN
cord-271653-4q2olzx1	20	28	due	due	JJ
cord-271653-4q2olzx1	20	29	to	to	IN
cord-271653-4q2olzx1	20	30	hypotension	hypotension	NN
cord-271653-4q2olzx1	20	31	and	and	CC
cord-271653-4q2olzx1	20	32	hypoxemia	hypoxemia	NN
cord-271653-4q2olzx1	20	33	can	can	MD
cord-271653-4q2olzx1	20	34	cause	cause	VB
cord-271653-4q2olzx1	20	35	myocardial	myocardial	JJ
cord-271653-4q2olzx1	20	36	injury	injury	NN
cord-271653-4q2olzx1	20	37	indirectly	indirectly	RB
cord-271653-4q2olzx1	20	38	.	.	.
cord-271653-4q2olzx1	21	1	Cytokines	cytokine	NNS
cord-271653-4q2olzx1	21	2	released	release	VBN
cord-271653-4q2olzx1	21	3	during	during	IN
cord-271653-4q2olzx1	21	4	the	the	DT
cord-271653-4q2olzx1	21	5	acute	acute	JJ
cord-271653-4q2olzx1	21	6	infection	infection	NN
cord-271653-4q2olzx1	21	7	can	can	MD
cord-271653-4q2olzx1	21	8	elicit	elicit	VB
cord-271653-4q2olzx1	21	9	activation	activation	NN
cord-271653-4q2olzx1	21	10	of	of	IN
cord-271653-4q2olzx1	21	11	cells	cell	NNS
cord-271653-4q2olzx1	21	12	within	within	IN
cord-271653-4q2olzx1	21	13	pre	pre	JJ
cord-271653-4q2olzx1	21	14	-	-	JJ
cord-271653-4q2olzx1	21	15	existing	existing	JJ
cord-271653-4q2olzx1	21	16	atherosclerotic	atherosclerotic	JJ
cord-271653-4q2olzx1	21	17	lesions	lesion	NNS
cord-271653-4q2olzx1	21	18	,	,	,
cord-271653-4q2olzx1	21	19	augmenting	augment	VBG
cord-271653-4q2olzx1	21	20	thrombotic	thrombotic	JJ
cord-271653-4q2olzx1	21	21	risk	risk	NN
cord-271653-4q2olzx1	21	22	and	and	CC
cord-271653-4q2olzx1	21	23	risk	risk	NN
cord-271653-4q2olzx1	21	24	of	of	IN
cord-271653-4q2olzx1	21	25	ischemic	ischemic	JJ
cord-271653-4q2olzx1	21	26	syndromes	syndrome	NNS
cord-271653-4q2olzx1	21	27	.	.	.
cord-271653-4q2olzx1	22	1	Moreover	moreover	RB
cord-271653-4q2olzx1	22	2	,	,	,
cord-271653-4q2olzx1	22	3	microvascular	microvascular	JJ
cord-271653-4q2olzx1	22	4	activation	activation	NN
cord-271653-4q2olzx1	22	5	by	by	IN
cord-271653-4q2olzx1	22	6	cytokines	cytokine	NNS
cord-271653-4q2olzx1	22	7	can	can	MD
cord-271653-4q2olzx1	22	8	cause	cause	VB
cord-271653-4q2olzx1	22	9	not	not	RB
cord-271653-4q2olzx1	22	10	only	only	RB
cord-271653-4q2olzx1	22	11	myocardial	myocardial	JJ
cord-271653-4q2olzx1	22	12	injury	injury	NN
cord-271653-4q2olzx1	22	13	but	but	CC
cord-271653-4q2olzx1	22	14	harm	harm	NN
cord-271653-4q2olzx1	22	15	other	other	JJ
cord-271653-4q2olzx1	22	16	organ	organ	NN
cord-271653-4q2olzx1	22	17	systems	system	NNS
cord-271653-4q2olzx1	22	18	commonly	commonly	RB
cord-271653-4q2olzx1	22	19	involved	involve	VBN
cord-271653-4q2olzx1	22	20	in	in	IN
cord-271653-4q2olzx1	22	21	COVID-19	covid-19	JJ
cord-271653-4q2olzx1	22	22	infections	infection	NNS
cord-271653-4q2olzx1	22	23	including	include	VBG
cord-271653-4q2olzx1	22	24	the	the	DT
cord-271653-4q2olzx1	22	25	kidneys	kidney	NNS
cord-271653-4q2olzx1	22	26	.	.	.
cord-271653-4q2olzx1	23	1	Dealing	deal	VBG
cord-271653-4q2olzx1	23	2	with	with	IN
cord-271653-4q2olzx1	23	3	the	the	DT
cord-271653-4q2olzx1	23	4	immense	immense	JJ
cord-271653-4q2olzx1	23	5	challenge	challenge	NN
cord-271653-4q2olzx1	23	6	of	of	IN
cord-271653-4q2olzx1	23	7	COVID-19	COVID-19	NNP
cord-271653-4q2olzx1	23	8	disease	disease	NN
cord-271653-4q2olzx1	23	9	,	,	,
cord-271653-4q2olzx1	23	10	confronted	confront	VBN
cord-271653-4q2olzx1	23	11	with	with	IN
cord-271653-4q2olzx1	23	12	severely	severely	RB
cord-271653-4q2olzx1	23	13	ill	ill	JJ
cord-271653-4q2olzx1	23	14	patients	patient	NNS
cord-271653-4q2olzx1	23	15	in	in	IN
cord-271653-4q2olzx1	23	16	dire	dire	JJ
cord-271653-4q2olzx1	23	17	straits	strait	NNS
cord-271653-4q2olzx1	23	18	with	with	IN
cord-271653-4q2olzx1	23	19	virtually	virtually	RB
cord-271653-4q2olzx1	23	20	no	no	DT
cord-271653-4q2olzx1	23	21	rigorous	rigorous	JJ
cord-271653-4q2olzx1	23	22	evidence	evidence	NN
cord-271653-4q2olzx1	23	23	base	base	NN
cord-271653-4q2olzx1	23	24	to	to	TO
cord-271653-4q2olzx1	23	25	guide	guide	VB
cord-271653-4q2olzx1	23	26	our	-PRON-	PRP$
cord-271653-4q2olzx1	23	27	therapy	therapy	NN
cord-271653-4q2olzx1	23	28	,	,	,
cord-271653-4q2olzx1	23	29	we	-PRON-	PRP
cord-271653-4q2olzx1	23	30	must	must	MD
cord-271653-4q2olzx1	23	31	call	call	VB
cord-271653-4q2olzx1	23	32	upon	upon	IN
cord-271653-4q2olzx1	23	33	our	-PRON-	PRP$
cord-271653-4q2olzx1	23	34	clinical	clinical	JJ
cord-271653-4q2olzx1	23	35	skills	skill	NNS
cord-271653-4q2olzx1	23	36	and	and	CC
cord-271653-4q2olzx1	23	37	judgment	judgment	NN
cord-271653-4q2olzx1	23	38	.	.	.
cord-271653-4q2olzx1	24	1	These	these	DT
cord-271653-4q2olzx1	24	2	touchstones	touchstone	NNS
cord-271653-4q2olzx1	24	3	can	can	MD
cord-271653-4q2olzx1	24	4	help	help	VB
cord-271653-4q2olzx1	24	5	guide	guide	VB
cord-271653-4q2olzx1	24	6	us	-PRON-	PRP
cord-271653-4q2olzx1	24	7	in	in	IN
cord-271653-4q2olzx1	24	8	selecting	select	VBG
cord-271653-4q2olzx1	24	9	patients	patient	NNS
cord-271653-4q2olzx1	24	10	who	who	WP
cord-271653-4q2olzx1	24	11	might	may	MD
cord-271653-4q2olzx1	24	12	benefit	benefit	VB
cord-271653-4q2olzx1	24	13	from	from	IN
cord-271653-4q2olzx1	24	14	the	the	DT
cord-271653-4q2olzx1	24	15	advanced	advanced	JJ
cord-271653-4q2olzx1	24	16	imaging	imaging	NN
cord-271653-4q2olzx1	24	17	and	and	CC
cord-271653-4q2olzx1	24	18	invasive	invasive	JJ
cord-271653-4q2olzx1	24	19	procedures	procedure	NNS
cord-271653-4q2olzx1	24	20	that	that	WDT
cord-271653-4q2olzx1	24	21	present	present	VBP
cord-271653-4q2olzx1	24	22	enormous	enormous	JJ
cord-271653-4q2olzx1	24	23	logistical	logistical	JJ
cord-271653-4q2olzx1	24	24	challenges	challenge	NNS
cord-271653-4q2olzx1	24	25	in	in	IN
cord-271653-4q2olzx1	24	26	the	the	DT
cord-271653-4q2olzx1	24	27	current	current	JJ
cord-271653-4q2olzx1	24	28	context	context	NN
cord-271653-4q2olzx1	24	29	.	.	.
cord-271653-4q2olzx1	25	1	Lacking	lack	VBG
cord-271653-4q2olzx1	25	2	a	a	DT
cord-271653-4q2olzx1	25	3	robust	robust	JJ
cord-271653-4q2olzx1	25	4	evidence	evidence	NN
cord-271653-4q2olzx1	25	5	base	base	NN
cord-271653-4q2olzx1	25	6	,	,	,
cord-271653-4q2olzx1	25	7	pathophysiologic	pathophysiologic	NN
cord-271653-4q2olzx1	25	8	reasoning	reasoning	NN
cord-271653-4q2olzx1	25	9	can	can	MD
cord-271653-4q2olzx1	25	10	help	help	VB
cord-271653-4q2olzx1	25	11	guide	guide	VB
cord-271653-4q2olzx1	25	12	our	-PRON-	PRP$
cord-271653-4q2olzx1	25	13	choices	choice	NNS
cord-271653-4q2olzx1	25	14	of	of	IN
cord-271653-4q2olzx1	25	15	therapy	therapy	NN
cord-271653-4q2olzx1	25	16	for	for	IN
cord-271653-4q2olzx1	25	17	individual	individual	JJ
cord-271653-4q2olzx1	25	18	clinical	clinical	JJ
cord-271653-4q2olzx1	25	19	scenarios	scenario	NNS
cord-271653-4q2olzx1	25	20	.	.	.
cord-271653-4q2olzx1	26	1	We	-PRON-	PRP
cord-271653-4q2olzx1	26	2	must	must	MD
cord-271653-4q2olzx1	26	3	exercise	exercise	VB
cord-271653-4q2olzx1	26	4	caution	caution	NN
cord-271653-4q2olzx1	26	5	and	and	CC
cord-271653-4q2olzx1	26	6	extreme	extreme	JJ
cord-271653-4q2olzx1	26	7	humility	humility	NN
cord-271653-4q2olzx1	26	8	,	,	,
cord-271653-4q2olzx1	26	9	as	as	IN
cord-271653-4q2olzx1	26	10	often	often	RB
cord-271653-4q2olzx1	26	11	plausible	plausible	JJ
cord-271653-4q2olzx1	26	12	interventions	intervention	NNS
cord-271653-4q2olzx1	26	13	fail	fail	VBP
cord-271653-4q2olzx1	26	14	when	when	WRB
cord-271653-4q2olzx1	26	15	tested	test	VBN
cord-271653-4q2olzx1	26	16	rigorously	rigorously	RB
cord-271653-4q2olzx1	26	17	.	.	.
cord-271653-4q2olzx1	27	1	But	but	CC
cord-271653-4q2olzx1	27	2	act	act	VB
cord-271653-4q2olzx1	27	3	today	today	NN
cord-271653-4q2olzx1	27	4	we	-PRON-	PRP
cord-271653-4q2olzx1	27	5	must	must	MD
cord-271653-4q2olzx1	27	6	,	,	,
cord-271653-4q2olzx1	27	7	and	and	CC
cord-271653-4q2olzx1	27	8	understanding	understand	VBG
cord-271653-4q2olzx1	27	9	the	the	DT
cord-271653-4q2olzx1	27	10	multiplicity	multiplicity	NN
cord-271653-4q2olzx1	27	11	of	of	IN
cord-271653-4q2olzx1	27	12	mechanisms	mechanism	NNS
cord-271653-4q2olzx1	27	13	of	of	IN
cord-271653-4q2olzx1	27	14	myocardial	myocardial	JJ
cord-271653-4q2olzx1	27	15	injury	injury	NN
cord-271653-4q2olzx1	27	16	in	in	IN
cord-271653-4q2olzx1	27	17	COVID-19	COVID-19	NNP
cord-271653-4q2olzx1	27	18	infection	infection	NN
cord-271653-4q2olzx1	27	19	will	will	MD
cord-271653-4q2olzx1	27	20	help	help	VB
cord-271653-4q2olzx1	27	21	us	-PRON-	PRP
cord-271653-4q2olzx1	27	22	meet	meet	VB
cord-271653-4q2olzx1	27	23	our	-PRON-	PRP$
cord-271653-4q2olzx1	27	24	mission	mission	NN
cord-271653-4q2olzx1	27	25	unsupported	unsupported	JJ
cord-271653-4q2olzx1	27	26	by	by	IN
cord-271653-4q2olzx1	27	27	the	the	DT
cord-271653-4q2olzx1	27	28	comfort	comfort	NN
cord-271653-4q2olzx1	27	29	of	of	IN
cord-271653-4q2olzx1	27	30	strong	strong	JJ
cord-271653-4q2olzx1	27	31	data	datum	NNS
cord-271653-4q2olzx1	27	32	.	.	.
cord-271653-4q2olzx1	28	1	In	in	IN
cord-271653-4q2olzx1	28	2	the	the	DT
cord-271653-4q2olzx1	28	3	throes	throe	NNS
cord-271653-4q2olzx1	28	4	of	of	IN
cord-271653-4q2olzx1	28	5	the	the	DT
cord-271653-4q2olzx1	28	6	current	current	JJ
cord-271653-4q2olzx1	28	7	pandemic	pandemic	NN
cord-271653-4q2olzx1	28	8	,	,	,
cord-271653-4q2olzx1	28	9	intense	intense	JJ
cord-271653-4q2olzx1	28	10	interest	interest	NN
cord-271653-4q2olzx1	28	11	has	have	VBZ
cord-271653-4q2olzx1	28	12	burgeoned	burgeon	VBN
cord-271653-4q2olzx1	28	13	in	in	IN
cord-271653-4q2olzx1	28	14	cardiovascular	cardiovascular	JJ
cord-271653-4q2olzx1	28	15	involvement	involvement	NN
cord-271653-4q2olzx1	28	16	by	by	IN
cord-271653-4q2olzx1	28	17	the	the	DT
cord-271653-4q2olzx1	28	18	novel	novel	JJ
cord-271653-4q2olzx1	28	19	coronavirus	coronavirus	NN
cord-271653-4q2olzx1	28	20	known	know	VBN
cord-271653-4q2olzx1	28	21	as	as	IN
cord-271653-4q2olzx1	28	22	COVID-19	COVID-19	NNP
cord-271653-4q2olzx1	28	23	.	.	.
cord-271653-4q2olzx1	29	1	Cardiologists	cardiologist	NNS
cord-271653-4q2olzx1	29	2	as	as	RB
cord-271653-4q2olzx1	29	3	well	well	RB
cord-271653-4q2olzx1	29	4	as	as	IN
cord-271653-4q2olzx1	29	5	other	other	JJ
cord-271653-4q2olzx1	29	6	practitioners	practitioner	NNS
cord-271653-4q2olzx1	29	7	who	who	WP
cord-271653-4q2olzx1	29	8	care	care	VBP
cord-271653-4q2olzx1	29	9	for	for	IN
cord-271653-4q2olzx1	29	10	those	those	DT
cord-271653-4q2olzx1	29	11	with	with	IN
cord-271653-4q2olzx1	29	12	this	this	DT
cord-271653-4q2olzx1	29	13	virulent	virulent	JJ
cord-271653-4q2olzx1	29	14	viral	viral	JJ
cord-271653-4q2olzx1	29	15	infection	infection	NN
cord-271653-4q2olzx1	29	16	,	,	,
cord-271653-4q2olzx1	29	17	and	and	CC
cord-271653-4q2olzx1	29	18	indeed	indeed	RB
cord-271653-4q2olzx1	29	19	the	the	DT
cord-271653-4q2olzx1	29	20	general	general	JJ
cord-271653-4q2olzx1	29	21	public	public	NN
cord-271653-4q2olzx1	29	22	as	as	IN
cord-271653-4q2olzx1	29	23	To	to	TO
cord-271653-4q2olzx1	29	24	approach	approach	VB
cord-271653-4q2olzx1	29	25	this	this	DT
cord-271653-4q2olzx1	29	26	question	question	NN
cord-271653-4q2olzx1	30	1	,	,	,
cord-271653-4q2olzx1	30	2	we	-PRON-	PRP
cord-271653-4q2olzx1	30	3	need	need	VBP
cord-271653-4q2olzx1	30	4	to	to	TO
cord-271653-4q2olzx1	30	5	distinguish	distinguish	VB
cord-271653-4q2olzx1	30	6	myocarditis	myocarditis	NN
cord-271653-4q2olzx1	30	7	due	due	IN
cord-271653-4q2olzx1	30	8	to	to	IN
cord-271653-4q2olzx1	30	9	infection	infection	NN
cord-271653-4q2olzx1	30	10	of	of	IN
cord-271653-4q2olzx1	30	11	cardiac	cardiac	JJ
cord-271653-4q2olzx1	30	12	cells	cell	NNS
cord-271653-4q2olzx1	30	13	from	from	IN
cord-271653-4q2olzx1	30	14	myocardial	myocardial	JJ
cord-271653-4q2olzx1	30	15	ischemic	ischemic	JJ
cord-271653-4q2olzx1	30	16	injury	injury	NN
cord-271653-4q2olzx1	30	17	.	.	.
cord-271653-4q2olzx1	31	1	Flow	flow	VB
cord-271653-4q2olzx1	31	2	embarrassment	embarrassment	NN
cord-271653-4q2olzx1	31	3	to	to	IN
cord-271653-4q2olzx1	31	4	the	the	DT
cord-271653-4q2olzx1	31	5	heart	heart	NN
cord-271653-4q2olzx1	31	6	muscle	muscle	NN
cord-271653-4q2olzx1	31	7	can	can	MD
cord-271653-4q2olzx1	31	8	result	result	VB
cord-271653-4q2olzx1	31	9	from	from	IN
cord-271653-4q2olzx1	31	10	lesions	lesion	NNS
cord-271653-4q2olzx1	31	11	in	in	IN
cord-271653-4q2olzx1	31	12	epicardial	epicardial	JJ
cord-271653-4q2olzx1	31	13	coronary	coronary	JJ
cord-271653-4q2olzx1	31	14	arteries	artery	NNS
cord-271653-4q2olzx1	31	15	or	or	CC
cord-271653-4q2olzx1	31	16	in	in	IN
cord-271653-4q2olzx1	31	17	the	the	DT
cord-271653-4q2olzx1	31	18	heart	heart	NN
cord-271653-4q2olzx1	31	19	's	's	POS
cord-271653-4q2olzx1	31	20	microvasculature	microvasculature	NN
cord-271653-4q2olzx1	31	21	.	.	.
cord-271653-4q2olzx1	32	1	Cardiac	cardiac	JJ
cord-271653-4q2olzx1	32	2	ischemia	ischemia	NN
cord-271653-4q2olzx1	32	3	can	can	MD
cord-271653-4q2olzx1	32	4	also	also	RB
cord-271653-4q2olzx1	32	5	arise	arise	VB
cord-271653-4q2olzx1	32	6	from	from	IN
cord-271653-4q2olzx1	32	7	an	an	DT
cord-271653-4q2olzx1	32	8	imbalance	imbalance	NN
cord-271653-4q2olzx1	32	9	between	between	IN
cord-271653-4q2olzx1	32	10	oxygen	oxygen	NN
cord-271653-4q2olzx1	32	11	supply	supply	NN
cord-271653-4q2olzx1	32	12	and	and	CC
cord-271653-4q2olzx1	32	13	demand	demand	NN
cord-271653-4q2olzx1	32	14	,	,	,
cord-271653-4q2olzx1	32	15	a	a	DT
cord-271653-4q2olzx1	32	16	type	type	NN
cord-271653-4q2olzx1	32	17	2	2	CD
cord-271653-4q2olzx1	32	18	acute	acute	JJ
cord-271653-4q2olzx1	32	19	coronary	coronary	JJ
cord-271653-4q2olzx1	32	20	syndrome	syndrome	NN
cord-271653-4q2olzx1	32	21	,	,	,
cord-271653-4q2olzx1	32	22	a	a	DT
cord-271653-4q2olzx1	32	23	situation	situation	NN
cord-271653-4q2olzx1	32	24	that	that	WDT
cord-271653-4q2olzx1	32	25	can	can	MD
cord-271653-4q2olzx1	32	26	prevail	prevail	VB
cord-271653-4q2olzx1	32	27	in	in	IN
cord-271653-4q2olzx1	32	28	acute	acute	JJ
cord-271653-4q2olzx1	32	29	infections	infection	NNS
cord-271653-4q2olzx1	32	30	,	,	,
cord-271653-4q2olzx1	32	31	particularly	particularly	RB
cord-271653-4q2olzx1	32	32	those	those	DT
cord-271653-4q2olzx1	32	33	that	that	WDT
cord-271653-4q2olzx1	32	34	affect	affect	VBP
cord-271653-4q2olzx1	32	35	the	the	DT
cord-271653-4q2olzx1	32	36	lungs	lung	NNS
cord-271653-4q2olzx1	32	37	like	like	IN
cord-271653-4q2olzx1	32	38	COVID19	COVID19	NNP
cord-271653-4q2olzx1	32	39	.	.	.
cord-271653-4q2olzx1	33	1	Several	several	JJ
cord-271653-4q2olzx1	33	2	of	of	IN
cord-271653-4q2olzx1	33	3	these	these	DT
cord-271653-4q2olzx1	33	4	pathophysiologic	pathophysiologic	JJ
cord-271653-4q2olzx1	33	5	pathways	pathway	NNS
cord-271653-4q2olzx1	33	6	to	to	IN
cord-271653-4q2olzx1	33	7	myocardial	myocardial	JJ
cord-271653-4q2olzx1	33	8	ischemia	ischemia	NN
cord-271653-4q2olzx1	33	9	may	may	MD
cord-271653-4q2olzx1	33	10	affect	affect	VB
cord-271653-4q2olzx1	33	11	those	those	DT
cord-271653-4q2olzx1	33	12	without	without	IN
cord-271653-4q2olzx1	33	13	substantial	substantial	JJ
cord-271653-4q2olzx1	33	14	or	or	CC
cord-271653-4q2olzx1	33	15	obstructive	obstructive	JJ
cord-271653-4q2olzx1	33	16	coronary	coronary	JJ
cord-271653-4q2olzx1	33	17	artery	artery	NN
cord-271653-4q2olzx1	33	18	atherosclerosis	atherosclerosis	NN
cord-271653-4q2olzx1	33	19	.	.	.
cord-271653-4q2olzx1	34	1	Hence	hence	RB
cord-271653-4q2olzx1	34	2	,	,	,
cord-271653-4q2olzx1	34	3	the	the	DT
cord-271653-4q2olzx1	34	4	distinction	distinction	NN
cord-271653-4q2olzx1	34	5	between	between	IN
cord-271653-4q2olzx1	34	6	these	these	DT
cord-271653-4q2olzx1	34	7	various	various	JJ
cord-271653-4q2olzx1	34	8	mechanisms	mechanism	NNS
cord-271653-4q2olzx1	34	9	has	have	VBZ
cord-271653-4q2olzx1	34	10	important	important	JJ
cord-271653-4q2olzx1	34	11	clinical	clinical	JJ
cord-271653-4q2olzx1	34	12	consequences	consequence	NNS
cord-271653-4q2olzx1	34	13	.	.	.
cord-271653-4q2olzx1	35	1	The	the	DT
cord-271653-4q2olzx1	35	2	need	need	NN
cord-271653-4q2olzx1	35	3	for	for	IN
cord-271653-4q2olzx1	35	4	arduous	arduous	JJ
cord-271653-4q2olzx1	35	5	imaging	imaging	NN
cord-271653-4q2olzx1	35	6	studies	study	NNS
cord-271653-4q2olzx1	35	7	and	and	CC
cord-271653-4q2olzx1	35	8	invasive	invasive	JJ
cord-271653-4q2olzx1	35	9	evaluation	evaluation	NN
cord-271653-4q2olzx1	35	10	may	may	MD
cord-271653-4q2olzx1	35	11	vary	vary	VB
cord-271653-4q2olzx1	35	12	considerably	considerably	RB
cord-271653-4q2olzx1	35	13	in	in	IN
cord-271653-4q2olzx1	35	14	these	these	DT
cord-271653-4q2olzx1	35	15	different	different	JJ
cord-271653-4q2olzx1	35	16	scenarios	scenario	NNS
cord-271653-4q2olzx1	35	17	,	,	,
cord-271653-4q2olzx1	35	18	an	an	DT
cord-271653-4q2olzx1	35	19	issue	issue	NN
cord-271653-4q2olzx1	35	20	of	of	IN
cord-271653-4q2olzx1	35	21	great	great	JJ
cord-271653-4q2olzx1	35	22	import	import	NN
cord-271653-4q2olzx1	35	23	in	in	IN
cord-271653-4q2olzx1	35	24	acute	acute	JJ
cord-271653-4q2olzx1	35	25	care	care	NN
cord-271653-4q2olzx1	35	26	facilities	facility	NNS
cord-271653-4q2olzx1	35	27	stretched	stretch	VBD
cord-271653-4q2olzx1	35	28	to	to	IN
cord-271653-4q2olzx1	35	29	or	or	CC
cord-271653-4q2olzx1	35	30	beyond	beyond	IN
cord-271653-4q2olzx1	35	31	their	-PRON-	PRP$
cord-271653-4q2olzx1	35	32	limits	limit	NNS
cord-271653-4q2olzx1	35	33	during	during	IN
cord-271653-4q2olzx1	35	34	a	a	DT
cord-271653-4q2olzx1	35	35	pandemic	pandemic	NN
cord-271653-4q2olzx1	35	36	with	with	IN
cord-271653-4q2olzx1	35	37	a	a	DT
cord-271653-4q2olzx1	35	38	readily	readily	RB
cord-271653-4q2olzx1	35	39	contagious	contagious	JJ
cord-271653-4q2olzx1	35	40	and	and	CC
cord-271653-4q2olzx1	35	41	virulent	virulent	JJ
cord-271653-4q2olzx1	35	42	infectious	infectious	JJ
cord-271653-4q2olzx1	35	43	agent	agent	NN
cord-271653-4q2olzx1	35	44	such	such	JJ
cord-271653-4q2olzx1	35	45	as	as	IN
cord-271653-4q2olzx1	35	46	COVID19	COVID19	NNP
cord-271653-4q2olzx1	35	47	.	.	.
cord-271653-4q2olzx1	36	1	Considering	consider	VBG
cord-271653-4q2olzx1	36	2	the	the	DT
cord-271653-4q2olzx1	36	3	pathophysiologic	pathophysiologic	JJ
cord-271653-4q2olzx1	36	4	paths	path	NNS
cord-271653-4q2olzx1	36	5	to	to	IN
cord-271653-4q2olzx1	36	6	cardiac	cardiac	JJ
cord-271653-4q2olzx1	36	7	injury	injury	NN
cord-271653-4q2olzx1	36	8	can	can	MD
cord-271653-4q2olzx1	36	9	inform	inform	VB
cord-271653-4q2olzx1	36	10	judgement	judgement	NN
cord-271653-4q2olzx1	36	11	regarding	regard	VBG
cord-271653-4q2olzx1	36	12	the	the	DT
cord-271653-4q2olzx1	36	13	necessity	necessity	NN
cord-271653-4q2olzx1	36	14	of	of	IN
cord-271653-4q2olzx1	36	15	transport	transport	NN
cord-271653-4q2olzx1	36	16	of	of	IN
cord-271653-4q2olzx1	36	17	severely	severely	RB
cord-271653-4q2olzx1	36	18	ill	ill	JJ
cord-271653-4q2olzx1	36	19	patients	patient	NNS
cord-271653-4q2olzx1	36	20	and	and	CC
cord-271653-4q2olzx1	36	21	the	the	DT
cord-271653-4q2olzx1	36	22	performance	performance	NN
cord-271653-4q2olzx1	36	23	invasive	invasive	JJ
cord-271653-4q2olzx1	36	24	procedures	procedure	NNS
cord-271653-4q2olzx1	36	25	.	.	.
cord-271653-4q2olzx1	36	26	 	 	_SP
cord-271653-4q2olzx1	37	1	The	the	DT
cord-271653-4q2olzx1	37	2	demographic	demographic	JJ
cord-271653-4q2olzx1	37	3	most	most	RBS
cord-271653-4q2olzx1	37	4	often	often	RB
cord-271653-4q2olzx1	37	5	affected	affect	VBN
cord-271653-4q2olzx1	37	6	by	by	IN
cord-271653-4q2olzx1	37	7	life	life	NN
cord-271653-4q2olzx1	37	8	-	-	HYPH
cord-271653-4q2olzx1	37	9	threatening	threaten	VBG
cord-271653-4q2olzx1	37	10	and	and	CC
cord-271653-4q2olzx1	37	11	fatal	fatal	JJ
cord-271653-4q2olzx1	37	12	COVID-19	covid-19	NN
cord-271653-4q2olzx1	37	13	has	have	VBZ
cord-271653-4q2olzx1	37	14	a	a	DT
cord-271653-4q2olzx1	37	15	high	high	JJ
cord-271653-4q2olzx1	37	16	prior	prior	JJ
cord-271653-4q2olzx1	37	17	probability	probability	NN
cord-271653-4q2olzx1	37	18	of	of	IN
cord-271653-4q2olzx1	37	19	pre	pre	JJ
cord-271653-4q2olzx1	37	20	-	-	JJ
cord-271653-4q2olzx1	37	21	existing	existing	JJ
cord-271653-4q2olzx1	37	22	atherosclerotic	atherosclerotic	JJ
cord-271653-4q2olzx1	37	23	lesions	lesion	NNS
cord-271653-4q2olzx1	37	24	:	:	:
cord-271653-4q2olzx1	37	25	the	the	DT
cord-271653-4q2olzx1	37	26	elderly	elderly	JJ
cord-271653-4q2olzx1	37	27	,	,	,
cord-271653-4q2olzx1	37	28	evident	evident	JJ
cord-271653-4q2olzx1	37	29	male	male	JJ
cord-271653-4q2olzx1	37	30	predominance	predominance	NN
cord-271653-4q2olzx1	37	31	,	,	,
cord-271653-4q2olzx1	37	32	and	and	CC
cord-271653-4q2olzx1	37	33	those	those	DT
cord-271653-4q2olzx1	37	34	with	with	IN
cord-271653-4q2olzx1	37	35	pre	pre	JJ
cord-271653-4q2olzx1	37	36	-	-	JJ
cord-271653-4q2olzx1	37	37	existing	existing	JJ
cord-271653-4q2olzx1	37	38	lung	lung	NN
cord-271653-4q2olzx1	37	39	disease	disease	NN
cord-271653-4q2olzx1	37	40	including	include	VBG
cord-271653-4q2olzx1	37	41	that	that	IN
cord-271653-4q2olzx1	37	42	associated	associate	VBN
cord-271653-4q2olzx1	37	43	with	with	IN
cord-271653-4q2olzx1	37	44	cigarette	cigarette	NN
cord-271653-4q2olzx1	37	45	smoking	smoking	NN
cord-271653-4q2olzx1	37	46	,	,	,
cord-271653-4q2olzx1	37	47	a	a	DT
cord-271653-4q2olzx1	37	48	risk	risk	NN
cord-271653-4q2olzx1	37	49	factor	factor	NN
cord-271653-4q2olzx1	37	50	for	for	IN
cord-271653-4q2olzx1	37	51	atherosclerosis	atherosclerosis	NN
cord-271653-4q2olzx1	37	52	.	.	.
cord-271653-4q2olzx1	38	1	Remote	remote	JJ
cord-271653-4q2olzx1	38	2	infections	infection	NNS
cord-271653-4q2olzx1	38	3	such	such	JJ
cord-271653-4q2olzx1	38	4	as	as	IN
cord-271653-4q2olzx1	38	5	the	the	DT
cord-271653-4q2olzx1	38	6	severe	severe	JJ
cord-271653-4q2olzx1	38	7	pneumonitis	pneumonitis	NN
cord-271653-4q2olzx1	38	8	that	that	IN
cord-271653-4q2olzx1	38	9	too	too	RB
cord-271653-4q2olzx1	38	10	commonly	commonly	RB
cord-271653-4q2olzx1	38	11	complicates	complicate	VBZ
cord-271653-4q2olzx1	38	12	COVID-19	COVID-19	NNP
cord-271653-4q2olzx1	38	13	can	can	MD
cord-271653-4q2olzx1	38	14	elicit	elicit	VB
cord-271653-4q2olzx1	38	15	an	an	DT
cord-271653-4q2olzx1	38	16	acute	acute	JJ
cord-271653-4q2olzx1	38	17	exacerbation	exacerbation	NN
cord-271653-4q2olzx1	38	18	of	of	IN
cord-271653-4q2olzx1	38	19	the	the	DT
cord-271653-4q2olzx1	38	20	chronic	chronic	JJ
cord-271653-4q2olzx1	38	21	smoldering	smolder	VBG
cord-271653-4q2olzx1	38	22	inflammation	inflammation	NN
cord-271653-4q2olzx1	38	23	that	that	WDT
cord-271653-4q2olzx1	38	24	characterizes	characterize	VBZ
cord-271653-4q2olzx1	38	25	coronary	coronary	JJ
cord-271653-4q2olzx1	38	26	atherosclerotic	atherosclerotic	JJ
cord-271653-4q2olzx1	38	27	lesions	lesion	NNS
cord-271653-4q2olzx1	38	28	(	(	-LRB-
cord-271653-4q2olzx1	38	29	Figure	figure	NN
cord-271653-4q2olzx1	38	30	2	2	CD
cord-271653-4q2olzx1	38	31	)	)	-RRB-
cord-271653-4q2olzx1	38	32	.	.	.
cord-271653-4q2olzx1	39	1	The	the	DT
cord-271653-4q2olzx1	39	2	inflammatory	inflammatory	JJ
cord-271653-4q2olzx1	39	3	cells	cell	NNS
cord-271653-4q2olzx1	39	4	at	at	IN
cord-271653-4q2olzx1	39	5	a	a	DT
cord-271653-4q2olzx1	39	6	site	site	NN
cord-271653-4q2olzx1	39	7	of	of	IN
cord-271653-4q2olzx1	39	8	regional	regional	JJ
cord-271653-4q2olzx1	39	9	infection	infection	NN
cord-271653-4q2olzx1	39	10	such	such	JJ
cord-271653-4q2olzx1	39	11	as	as	IN
cord-271653-4q2olzx1	39	12	the	the	DT
cord-271653-4q2olzx1	39	13	lungs	lung	NNS
cord-271653-4q2olzx1	39	14	in	in	IN
cord-271653-4q2olzx1	39	15	COVID19	COVID19	NNP
cord-271653-4q2olzx1	39	16	pneumonitis	pneumonitis	NN
cord-271653-4q2olzx1	39	17	can	can	MD
cord-271653-4q2olzx1	39	18	produce	produce	VB
cord-271653-4q2olzx1	39	19	cytokines	cytokine	NNS
cord-271653-4q2olzx1	39	20	such	such	JJ
cord-271653-4q2olzx1	39	21	as	as	IN
cord-271653-4q2olzx1	39	22	interleukins	interleukin	NNS
cord-271653-4q2olzx1	39	23	(	(	-LRB-
cord-271653-4q2olzx1	39	24	IL)-1	il)-1	JJ
cord-271653-4q2olzx1	39	25	and	and	CC
cord-271653-4q2olzx1	39	26	-6	-6	NNP
cord-271653-4q2olzx1	39	27	,	,	,
cord-271653-4q2olzx1	39	28	and	and	CC
cord-271653-4q2olzx1	39	29	tumor	tumor	NN
cord-271653-4q2olzx1	39	30	necrosis	necrosis	NN
cord-271653-4q2olzx1	39	31	factor	factor	NN
cord-271653-4q2olzx1	39	32	,	,	,
cord-271653-4q2olzx1	39	33	mediators	mediator	NNS
cord-271653-4q2olzx1	39	34	that	that	IN
cord-271653-4q2olzx1	39	35	not	not	RB
cord-271653-4q2olzx1	39	36	only	only	RB
cord-271653-4q2olzx1	39	37	propagate	propagate	VBP
cord-271653-4q2olzx1	39	38	local	local	JJ
cord-271653-4q2olzx1	39	39	inflammation	inflammation	NN
cord-271653-4q2olzx1	39	40	but	but	CC
cord-271653-4q2olzx1	39	41	can	can	MD
cord-271653-4q2olzx1	39	42	enter	enter	VB
cord-271653-4q2olzx1	39	43	the	the	DT
cord-271653-4q2olzx1	39	44	systemic	systemic	JJ
cord-271653-4q2olzx1	39	45	circulation	circulation	NN
cord-271653-4q2olzx1	39	46	.	.	.
cord-271653-4q2olzx1	40	1	Such	such	JJ
cord-271653-4q2olzx1	40	2	circulating	circulate	VBG
cord-271653-4q2olzx1	40	3	cytokines	cytokine	NNS
cord-271653-4q2olzx1	40	4	can	can	MD
cord-271653-4q2olzx1	40	5	stimulate	stimulate	VB
cord-271653-4q2olzx1	40	6	macrophages	macrophage	NNS
cord-271653-4q2olzx1	40	7	within	within	IN
cord-271653-4q2olzx1	40	8	the	the	DT
cord-271653-4q2olzx1	40	9	plaque	plaque	NN
cord-271653-4q2olzx1	40	10	to	to	TO
cord-271653-4q2olzx1	40	11	augment	augment	VB
cord-271653-4q2olzx1	40	12	local	local	JJ
cord-271653-4q2olzx1	40	13	cytokine	cytokine	NN
cord-271653-4q2olzx1	40	14	production	production	NN
cord-271653-4q2olzx1	40	15	and	and	CC
cord-271653-4q2olzx1	40	16	provoke	provoke	VB
cord-271653-4q2olzx1	40	17	an	an	DT
cord-271653-4q2olzx1	40	18	increase	increase	NN
cord-271653-4q2olzx1	40	19	in	in	IN
cord-271653-4q2olzx1	40	20	tissue	tissue	NN
cord-271653-4q2olzx1	40	21	factor	factor	NN
cord-271653-4q2olzx1	40	22	expression	expression	NN
cord-271653-4q2olzx1	40	23	that	that	WDT
cord-271653-4q2olzx1	40	24	renders	render	VBZ
cord-271653-4q2olzx1	40	25	lesions	lesion	NNS
cord-271653-4q2olzx1	40	26	more	more	RBR
cord-271653-4q2olzx1	40	27	thrombogenic	thrombogenic	JJ
cord-271653-4q2olzx1	40	28	.	.	.
cord-271653-4q2olzx1	41	1	We	-PRON-	PRP
cord-271653-4q2olzx1	41	2	have	have	VBP
cord-271653-4q2olzx1	41	3	referred	refer	VBN
cord-271653-4q2olzx1	41	4	to	to	IN
cord-271653-4q2olzx1	41	5	this	this	DT
cord-271653-4q2olzx1	41	6	local	local	JJ
cord-271653-4q2olzx1	41	7	response	response	NN
cord-271653-4q2olzx1	41	8	to	to	IN
cord-271653-4q2olzx1	41	9	systemic	systemic	JJ
cord-271653-4q2olzx1	41	10	stimuli	stimulus	NNS
cord-271653-4q2olzx1	41	11	as	as	IN
cord-271653-4q2olzx1	41	12	an	an	DT
cord-271653-4q2olzx1	41	13	"	"	``
cord-271653-4q2olzx1	41	14	echo	echo	NN
cord-271653-4q2olzx1	41	15	"	"	''
cord-271653-4q2olzx1	41	16	phenomenon	phenomenon	NN
cord-271653-4q2olzx1	41	17	.	.	.
cord-271653-4q2olzx1	42	1	4	4	LS
cord-271653-4q2olzx1	42	2	,	,	,
cord-271653-4q2olzx1	42	3	6	6	CD
cord-271653-4q2olzx1	42	4	These	these	DT
cord-271653-4q2olzx1	42	5	same	same	JJ
cord-271653-4q2olzx1	42	6	systemic	systemic	JJ
cord-271653-4q2olzx1	42	7	cytokines	cytokine	NNS
cord-271653-4q2olzx1	42	8	can	can	MD
cord-271653-4q2olzx1	42	9	stimulate	stimulate	VB
cord-271653-4q2olzx1	42	10	leukocyte	leukocyte	NN
cord-271653-4q2olzx1	42	11	adhesion	adhesion	NN
cord-271653-4q2olzx1	42	12	molecule	molecule	NN
cord-271653-4q2olzx1	42	13	expression	expression	NN
cord-271653-4q2olzx1	42	14	on	on	IN
cord-271653-4q2olzx1	42	15	the	the	DT
cord-271653-4q2olzx1	42	16	endothelial	endothelial	JJ
cord-271653-4q2olzx1	42	17	cells	cell	NNS
cord-271653-4q2olzx1	42	18	overlying	overlie	VBG
cord-271653-4q2olzx1	42	19	established	establish	VBN
cord-271653-4q2olzx1	42	20	atheroma	atheroma	NNP
cord-271653-4q2olzx1	42	21	,	,	,
cord-271653-4q2olzx1	42	22	boosting	boost	VBG
cord-271653-4q2olzx1	42	23	local	local	JJ
cord-271653-4q2olzx1	42	24	recruitment	recruitment	NN
cord-271653-4q2olzx1	42	25	of	of	IN
cord-271653-4q2olzx1	42	26	these	these	DT
cord-271653-4q2olzx1	42	27	inflammatory	inflammatory	JJ
cord-271653-4q2olzx1	42	28	cells	cell	NNS
cord-271653-4q2olzx1	42	29	.	.	.
cord-271653-4q2olzx1	43	1	These	these	DT
cord-271653-4q2olzx1	43	2	alterations	alteration	NNS
cord-271653-4q2olzx1	43	3	in	in	IN
cord-271653-4q2olzx1	43	4	preexisting	preexisting	JJ
cord-271653-4q2olzx1	43	5	plaques	plaque	NNS
cord-271653-4q2olzx1	43	6	can	can	MD
cord-271653-4q2olzx1	43	7	enhance	enhance	VB
cord-271653-4q2olzx1	43	8	their	-PRON-	PRP$
cord-271653-4q2olzx1	43	9	propensity	propensity	NN
cord-271653-4q2olzx1	43	10	to	to	TO
cord-271653-4q2olzx1	43	11	disrupt	disrupt	VB
cord-271653-4q2olzx1	43	12	,	,	,
cord-271653-4q2olzx1	43	13	be	be	VB
cord-271653-4q2olzx1	43	14	it	-PRON-	PRP
cord-271653-4q2olzx1	43	15	by	by	IN
cord-271653-4q2olzx1	43	16	fibrous	fibrous	JJ
cord-271653-4q2olzx1	43	17	cap	cap	NN
cord-271653-4q2olzx1	43	18	fissure	fissure	NN
cord-271653-4q2olzx1	43	19	or	or	CC
cord-271653-4q2olzx1	43	20	by	by	IN
cord-271653-4q2olzx1	43	21	superficial	superficial	JJ
cord-271653-4q2olzx1	43	22	erosion	erosion	NN
cord-271653-4q2olzx1	43	23	,	,	,
cord-271653-4q2olzx1	43	24	and	and	CC
cord-271653-4q2olzx1	43	25	provoke	provoke	VB
cord-271653-4q2olzx1	43	26	an	an	DT
cord-271653-4q2olzx1	43	27	acute	acute	JJ
cord-271653-4q2olzx1	43	28	coronary	coronary	JJ
cord-271653-4q2olzx1	43	29	syndrome	syndrome	NN
cord-271653-4q2olzx1	43	30	.	.	.
cord-271653-4q2olzx1	44	1	Even	even	RB
cord-271653-4q2olzx1	44	2	in	in	IN
cord-271653-4q2olzx1	44	3	individuals	individual	NNS
cord-271653-4q2olzx1	44	4	without	without	IN
cord-271653-4q2olzx1	44	5	pre	pre	JJ
cord-271653-4q2olzx1	44	6	-	-	JJ
cord-271653-4q2olzx1	44	7	existing	existing	JJ
cord-271653-4q2olzx1	44	8	epicardial	epicardial	JJ
cord-271653-4q2olzx1	44	9	coronary	coronary	JJ
cord-271653-4q2olzx1	44	10	artery	artery	NN
cord-271653-4q2olzx1	44	11	disease	disease	NN
cord-271653-4q2olzx1	44	12	,	,	,
cord-271653-4q2olzx1	44	13	systemic	systemic	JJ
cord-271653-4q2olzx1	44	14	cytokines	cytokine	NNS
cord-271653-4q2olzx1	44	15	released	release	VBN
cord-271653-4q2olzx1	44	16	from	from	IN
cord-271653-4q2olzx1	44	17	sites	site	NNS
cord-271653-4q2olzx1	44	18	of	of	IN
cord-271653-4q2olzx1	44	19	local	local	JJ
cord-271653-4q2olzx1	44	20	infections	infection	NNS
cord-271653-4q2olzx1	44	21	such	such	JJ
cord-271653-4q2olzx1	44	22	as	as	IN
cord-271653-4q2olzx1	44	23	in	in	IN
cord-271653-4q2olzx1	44	24	pneumonitis	pneumonitis	NN
cord-271653-4q2olzx1	44	25	can	can	MD
cord-271653-4q2olzx1	44	26	affect	affect	VB
cord-271653-4q2olzx1	44	27	intermural	intermural	JJ
cord-271653-4q2olzx1	44	28	coronary	coronary	JJ
cord-271653-4q2olzx1	44	29	vessels	vessel	NNS
cord-271653-4q2olzx1	44	30	.	.	.
cord-271653-4q2olzx1	45	1	They	-PRON-	PRP
cord-271653-4q2olzx1	45	2	also	also	RB
cord-271653-4q2olzx1	45	3	can	can	MD
cord-271653-4q2olzx1	45	4	activate	activate	VB
cord-271653-4q2olzx1	45	5	the	the	DT
cord-271653-4q2olzx1	45	6	microvascular	microvascular	JJ
cord-271653-4q2olzx1	45	7	endothelium	endothelium	NN
cord-271653-4q2olzx1	45	8	,	,	,
cord-271653-4q2olzx1	45	9	predisposing	predispose	VBG
cord-271653-4q2olzx1	45	10	to	to	IN
cord-271653-4q2olzx1	45	11	vasomotor	vasomotor	NN
cord-271653-4q2olzx1	45	12	abnormalities	abnormality	NNS
cord-271653-4q2olzx1	45	13	,	,	,
cord-271653-4q2olzx1	45	14	augmented	augment	VBN
cord-271653-4q2olzx1	45	15	thrombosis	thrombosis	NN
cord-271653-4q2olzx1	45	16	,	,	,
cord-271653-4q2olzx1	45	17	reduced	reduce	VBN
cord-271653-4q2olzx1	45	18	fibrinolysis	fibrinolysis	NN
cord-271653-4q2olzx1	45	19	,	,	,
cord-271653-4q2olzx1	45	20	increased	increase	VBN
cord-271653-4q2olzx1	45	21	leukocyte	leukocyte	NN
cord-271653-4q2olzx1	45	22	adhesion	adhesion	NN
cord-271653-4q2olzx1	45	23	,	,	,
cord-271653-4q2olzx1	45	24	and	and	CC
cord-271653-4q2olzx1	45	25	other	other	JJ
cord-271653-4q2olzx1	45	26	aspects	aspect	NNS
cord-271653-4q2olzx1	45	27	of	of	IN
cord-271653-4q2olzx1	45	28	dysfunction	dysfunction	NN
cord-271653-4q2olzx1	45	29	of	of	IN
cord-271653-4q2olzx1	45	30	the	the	DT
cord-271653-4q2olzx1	45	31	microvessels	microvessel	NNS
cord-271653-4q2olzx1	45	32	of	of	IN
cord-271653-4q2olzx1	45	33	the	the	DT
cord-271653-4q2olzx1	45	34	coronary	coronary	JJ
cord-271653-4q2olzx1	45	35	circulation	circulation	NN
cord-271653-4q2olzx1	45	36	.	.	.
cord-271653-4q2olzx1	46	1	These	these	DT
cord-271653-4q2olzx1	46	2	effects	effect	NNS
cord-271653-4q2olzx1	46	3	wrought	work	VBN
cord-271653-4q2olzx1	46	4	by	by	IN
cord-271653-4q2olzx1	46	5	distant	distant	JJ
cord-271653-4q2olzx1	46	6	infection	infection	NN
cord-271653-4q2olzx1	46	7	can	can	MD
cord-271653-4q2olzx1	46	8	contribute	contribute	VB
cord-271653-4q2olzx1	46	9	to	to	IN
cord-271653-4q2olzx1	46	10	myocardial	myocardial	JJ
cord-271653-4q2olzx1	46	11	ischemia	ischemia	NN
cord-271653-4q2olzx1	46	12	even	even	RB
cord-271653-4q2olzx1	46	13	in	in	IN
cord-271653-4q2olzx1	46	14	the	the	DT
cord-271653-4q2olzx1	46	15	absence	absence	NN
cord-271653-4q2olzx1	46	16	of	of	IN
cord-271653-4q2olzx1	46	17	epicardial	epicardial	JJ
cord-271653-4q2olzx1	46	18	atherosclerosis	atherosclerosis	NN
cord-271653-4q2olzx1	46	19	,	,	,
cord-271653-4q2olzx1	46	20	and	and	CC
cord-271653-4q2olzx1	46	21	could	could	MD
cord-271653-4q2olzx1	46	22	compound	compound	VB
cord-271653-4q2olzx1	46	23	cardiac	cardiac	JJ
cord-271653-4q2olzx1	46	24	injury	injury	NN
cord-271653-4q2olzx1	46	25	in	in	IN
cord-271653-4q2olzx1	46	26	those	those	DT
cord-271653-4q2olzx1	46	27	with	with	IN
cord-271653-4q2olzx1	46	28	flow	flow	NN
cord-271653-4q2olzx1	46	29	limitation	limitation	NN
cord-271653-4q2olzx1	46	30	due	due	JJ
cord-271653-4q2olzx1	46	31	to	to	IN
cord-271653-4q2olzx1	46	32	plaque	plaque	NN
cord-271653-4q2olzx1	46	33	in	in	IN
cord-271653-4q2olzx1	46	34	the	the	DT
cord-271653-4q2olzx1	46	35	larger	large	JJR
cord-271653-4q2olzx1	46	36	coronary	coronary	JJ
cord-271653-4q2olzx1	46	37	arteries	artery	NNS
cord-271653-4q2olzx1	46	38	.	.	.
cord-271653-4q2olzx1	47	1	The	the	DT
cord-271653-4q2olzx1	47	2	cardinal	cardinal	JJ
cord-271653-4q2olzx1	47	3	signs	sign	NNS
cord-271653-4q2olzx1	47	4	of	of	IN
cord-271653-4q2olzx1	47	5	infection	infection	NN
cord-271653-4q2olzx1	47	6	include	include	VBP
cord-271653-4q2olzx1	47	7	fever	fever	NN
cord-271653-4q2olzx1	47	8	and	and	CC
cord-271653-4q2olzx1	47	9	tachycardia	tachycardia	NN
cord-271653-4q2olzx1	47	10	,	,	,
cord-271653-4q2olzx1	47	11	circumstances	circumstance	NNS
cord-271653-4q2olzx1	47	12	that	that	WDT
cord-271653-4q2olzx1	47	13	increase	increase	VBP
cord-271653-4q2olzx1	47	14	the	the	DT
cord-271653-4q2olzx1	47	15	oxygen	oxygen	NN
cord-271653-4q2olzx1	47	16	requirements	requirement	NNS
cord-271653-4q2olzx1	47	17	of	of	IN
cord-271653-4q2olzx1	47	18	the	the	DT
cord-271653-4q2olzx1	47	19	myocardium	myocardium	NN
cord-271653-4q2olzx1	47	20	(	(	-LRB-
cord-271653-4q2olzx1	47	21	Figure	figure	NN
cord-271653-4q2olzx1	47	22	3	3	CD
cord-271653-4q2olzx1	47	23	)	)	-RRB-
cord-271653-4q2olzx1	47	24	.	.	.
cord-271653-4q2olzx1	48	1	Hypoxemia	Hypoxemia	NNP
cord-271653-4q2olzx1	48	2	produced	produce	VBN
cord-271653-4q2olzx1	48	3	by	by	IN
cord-271653-4q2olzx1	48	4	pneumonitis	pneumonitis	NN
cord-271653-4q2olzx1	48	5	can	can	MD
cord-271653-4q2olzx1	48	6	decrease	decrease	VB
cord-271653-4q2olzx1	48	7	oxygen	oxygen	NN
cord-271653-4q2olzx1	48	8	delivery	delivery	NN
cord-271653-4q2olzx1	48	9	to	to	IN
cord-271653-4q2olzx1	48	10	the	the	DT
cord-271653-4q2olzx1	48	11	myocardium	myocardium	NN
cord-271653-4q2olzx1	48	12	.	.	.
cord-271653-4q2olzx1	49	1	Hypotension	hypotension	NN
cord-271653-4q2olzx1	49	2	in	in	IN
cord-271653-4q2olzx1	49	3	sepsis	sepsis	NN
cord-271653-4q2olzx1	49	4	and	and	CC
cord-271653-4q2olzx1	49	5	in	in	IN
cord-271653-4q2olzx1	49	6	cytokine	cytokine	NN
cord-271653-4q2olzx1	49	7	storm	storm	NN
cord-271653-4q2olzx1	49	8	can	can	MD
cord-271653-4q2olzx1	49	9	impair	impair	VB
cord-271653-4q2olzx1	49	10	coronary	coronary	JJ
cord-271653-4q2olzx1	49	11	perfusion	perfusion	NN
cord-271653-4q2olzx1	49	12	.	.	.
cord-271653-4q2olzx1	50	1	Together	together	RB
cord-271653-4q2olzx1	50	2	these	these	DT
cord-271653-4q2olzx1	50	3	systemic	systemic	JJ
cord-271653-4q2olzx1	50	4	effects	effect	NNS
cord-271653-4q2olzx1	50	5	of	of	IN
cord-271653-4q2olzx1	50	6	infection	infection	NN
cord-271653-4q2olzx1	50	7	conspire	conspire	VBP
cord-271653-4q2olzx1	50	8	to	to	TO
cord-271653-4q2olzx1	50	9	limit	limit	VB
cord-271653-4q2olzx1	50	10	blood	blood	NN
cord-271653-4q2olzx1	50	11	flow	flow	NN
cord-271653-4q2olzx1	50	12	in	in	IN
cord-271653-4q2olzx1	50	13	the	the	DT
cord-271653-4q2olzx1	50	14	coronary	coronary	JJ
cord-271653-4q2olzx1	50	15	arteries	artery	NNS
cord-271653-4q2olzx1	50	16	,	,	,
cord-271653-4q2olzx1	50	17	and	and	CC
cord-271653-4q2olzx1	50	18	reduce	reduce	VB
cord-271653-4q2olzx1	50	19	oxygen	oxygen	NN
cord-271653-4q2olzx1	50	20	supply	supply	NN
cord-271653-4q2olzx1	50	21	while	while	IN
cord-271653-4q2olzx1	50	22	augmenting	augment	VBG
cord-271653-4q2olzx1	50	23	myocardial	myocardial	JJ
cord-271653-4q2olzx1	50	24	oxygen	oxygen	NN
cord-271653-4q2olzx1	50	25	demand	demand	NN
cord-271653-4q2olzx1	50	26	.	.	.
cord-271653-4q2olzx1	51	1	These	these	DT
cord-271653-4q2olzx1	51	2	consequences	consequence	NNS
cord-271653-4q2olzx1	51	3	of	of	IN
cord-271653-4q2olzx1	51	4	infection	infection	NN
cord-271653-4q2olzx1	51	5	predispose	predispose	VBP
cord-271653-4q2olzx1	51	6	to	to	IN
cord-271653-4q2olzx1	51	7	myocardial	myocardial	JJ
cord-271653-4q2olzx1	51	8	ischemia	ischemia	NN
cord-271653-4q2olzx1	51	9	.	.	.
cord-271653-4q2olzx1	52	1	They	-PRON-	PRP
cord-271653-4q2olzx1	52	2	may	may	MD
cord-271653-4q2olzx1	52	3	aggravate	aggravate	VB
cord-271653-4q2olzx1	52	4	the	the	DT
cord-271653-4q2olzx1	52	5	consequences	consequence	NNS
cord-271653-4q2olzx1	52	6	of	of	IN
cord-271653-4q2olzx1	52	7	plaques	plaque	NNS
cord-271653-4q2olzx1	52	8	that	that	WDT
cord-271653-4q2olzx1	52	9	would	would	MD
cord-271653-4q2olzx1	52	10	not	not	RB
cord-271653-4q2olzx1	52	11	limit	limit	VB
cord-271653-4q2olzx1	52	12	flow	flow	NN
cord-271653-4q2olzx1	52	13	or	or	CC
cord-271653-4q2olzx1	52	14	provoke	provoke	VB
cord-271653-4q2olzx1	52	15	ischemia	ischemia	NN
cord-271653-4q2olzx1	52	16	under	under	IN
cord-271653-4q2olzx1	52	17	usual	usual	JJ
cord-271653-4q2olzx1	52	18	conditions	condition	NNS
cord-271653-4q2olzx1	52	19	,	,	,
cord-271653-4q2olzx1	52	20	and	and	CC
cord-271653-4q2olzx1	52	21	could	could	MD
cord-271653-4q2olzx1	52	22	produce	produce	VB
cord-271653-4q2olzx1	52	23	ischemic	ischemic	JJ
cord-271653-4q2olzx1	52	24	injury	injury	NN
cord-271653-4q2olzx1	52	25	even	even	RB
cord-271653-4q2olzx1	52	26	in	in	IN
cord-271653-4q2olzx1	52	27	those	those	DT
cord-271653-4q2olzx1	52	28	with	with	IN
cord-271653-4q2olzx1	52	29	little	little	JJ
cord-271653-4q2olzx1	52	30	or	or	CC
cord-271653-4q2olzx1	52	31	no	no	DT
cord-271653-4q2olzx1	52	32	coronary	coronary	JJ
cord-271653-4q2olzx1	52	33	artery	artery	NN
cord-271653-4q2olzx1	52	34	atherosclerosis	atherosclerosis	NN
cord-271653-4q2olzx1	52	35	.	.	.
cord-271653-4q2olzx1	53	1	At	at	IN
cord-271653-4q2olzx1	53	2	one	one	CD
cord-271653-4q2olzx1	53	3	end	end	NN
cord-271653-4q2olzx1	53	4	of	of	IN
cord-271653-4q2olzx1	53	5	the	the	DT
cord-271653-4q2olzx1	53	6	spectrum	spectrum	NN
cord-271653-4q2olzx1	53	7	,	,	,
cord-271653-4q2olzx1	53	8	a	a	DT
cord-271653-4q2olzx1	53	9	young	young	JJ
cord-271653-4q2olzx1	53	10	individual	individual	NN
cord-271653-4q2olzx1	53	11	with	with	IN
cord-271653-4q2olzx1	53	12	pristine	pristine	JJ
cord-271653-4q2olzx1	53	13	coronary	coronary	JJ
cord-271653-4q2olzx1	53	14	arteries	artery	NNS
cord-271653-4q2olzx1	53	15	might	may	MD
cord-271653-4q2olzx1	53	16	suffer	suffer	VB
cord-271653-4q2olzx1	53	17	severe	severe	JJ
cord-271653-4q2olzx1	53	18	myocardial	myocardial	JJ
cord-271653-4q2olzx1	53	19	injury	injury	NN
cord-271653-4q2olzx1	53	20	due	due	IN
cord-271653-4q2olzx1	53	21	to	to	IN
cord-271653-4q2olzx1	53	22	a	a	DT
cord-271653-4q2olzx1	53	23	fulminant	fulminant	JJ
cord-271653-4q2olzx1	53	24	myocarditis	myocarditis	NN
cord-271653-4q2olzx1	53	25	caused	cause	VBN
cord-271653-4q2olzx1	53	26	by	by	IN
cord-271653-4q2olzx1	53	27	direct	direct	JJ
cord-271653-4q2olzx1	53	28	infection	infection	NN
cord-271653-4q2olzx1	53	29	with	with	IN
cord-271653-4q2olzx1	53	30	COVID-19	COVID-19	NNP
cord-271653-4q2olzx1	53	31	(	(	-LRB-
cord-271653-4q2olzx1	53	32	Figure	figure	NN
cord-271653-4q2olzx1	53	33	1	1	CD
cord-271653-4q2olzx1	53	34	,	,	,
cord-271653-4q2olzx1	53	35	left	leave	VBN
cord-271653-4q2olzx1	53	36	)	)	-RRB-
cord-271653-4q2olzx1	53	37	.	.	.
cord-271653-4q2olzx1	54	1	At	at	IN
cord-271653-4q2olzx1	54	2	the	the	DT
cord-271653-4q2olzx1	54	3	other	other	JJ
cord-271653-4q2olzx1	54	4	extreme	extreme	NN
cord-271653-4q2olzx1	54	5	,	,	,
cord-271653-4q2olzx1	54	6	a	a	DT
cord-271653-4q2olzx1	54	7	person	person	NN
cord-271653-4q2olzx1	54	8	with	with	IN
cord-271653-4q2olzx1	54	9	advanced	advanced	JJ
cord-271653-4q2olzx1	54	10	coronary	coronary	JJ
cord-271653-4q2olzx1	54	11	atherosclerosis	atherosclerosis	NN
cord-271653-4q2olzx1	54	12	could	could	MD
cord-271653-4q2olzx1	54	13	suffer	suffer	VB
cord-271653-4q2olzx1	54	14	a	a	DT
cord-271653-4q2olzx1	54	15	type	type	NN
cord-271653-4q2olzx1	54	16	1	1	CD
cord-271653-4q2olzx1	54	17	or	or	CC
cord-271653-4q2olzx1	54	18	type	type	NN
cord-271653-4q2olzx1	54	19	2	2	CD
cord-271653-4q2olzx1	54	20	acute	acute	JJ
cord-271653-4q2olzx1	54	21	myocardial	myocardial	JJ
cord-271653-4q2olzx1	54	22	infarction	infarction	NN
cord-271653-4q2olzx1	54	23	without	without	IN
cord-271653-4q2olzx1	54	24	direct	direct	JJ
cord-271653-4q2olzx1	54	25	viral	viral	JJ
cord-271653-4q2olzx1	54	26	infection	infection	NN
cord-271653-4q2olzx1	54	27	of	of	IN
cord-271653-4q2olzx1	54	28	cardiac	cardiac	JJ
cord-271653-4q2olzx1	54	29	cells	cell	NNS
cord-271653-4q2olzx1	54	30	(	(	-LRB-
cord-271653-4q2olzx1	54	31	Figure	figure	NN
cord-271653-4q2olzx1	54	32	1	1	CD
cord-271653-4q2olzx1	54	33	,	,	,
cord-271653-4q2olzx1	54	34	right	right	RB
cord-271653-4q2olzx1	54	35	)	)	-RRB-
cord-271653-4q2olzx1	54	36	.	.	.
cord-271653-4q2olzx1	55	1	Although	although	IN
cord-271653-4q2olzx1	55	2	we	-PRON-	PRP
cord-271653-4q2olzx1	55	3	are	be	VBP
cord-271653-4q2olzx1	55	4	early	early	JJ
cord-271653-4q2olzx1	55	5	in	in	IN
cord-271653-4q2olzx1	55	6	our	-PRON-	PRP$
cord-271653-4q2olzx1	55	7	experience	experience	NN
cord-271653-4q2olzx1	55	8	with	with	IN
cord-271653-4q2olzx1	55	9	this	this	DT
cord-271653-4q2olzx1	55	10	novel	novel	JJ
cord-271653-4q2olzx1	55	11	coronavirus	coronavirus	NN
cord-271653-4q2olzx1	55	12	disease	disease	NN
cord-271653-4q2olzx1	55	13	,	,	,
cord-271653-4q2olzx1	55	14	most	most	JJS
cord-271653-4q2olzx1	55	15	patients	patient	NNS
cord-271653-4q2olzx1	55	16	affected	affect	VBN
cord-271653-4q2olzx1	55	17	by	by	IN
cord-271653-4q2olzx1	55	18	COVID-19	COVID-19	NNP
cord-271653-4q2olzx1	55	19	encountered	encounter	VBN
cord-271653-4q2olzx1	55	20	by	by	IN
cord-271653-4q2olzx1	55	21	cardiologists	cardiologist	NNS
cord-271653-4q2olzx1	55	22	may	may	MD
cord-271653-4q2olzx1	55	23	have	have	VB
cord-271653-4q2olzx1	55	24	more	more	JJR
cord-271653-4q2olzx1	55	25	secondary	secondary	JJ
cord-271653-4q2olzx1	55	26	cardiac	cardiac	JJ
cord-271653-4q2olzx1	55	27	involvement	involvement	NN
cord-271653-4q2olzx1	55	28	then	then	RB
cord-271653-4q2olzx1	55	29	primary	primary	JJ
cord-271653-4q2olzx1	55	30	infective	infective	JJ
cord-271653-4q2olzx1	55	31	myocarditis	myocarditis	NN
cord-271653-4q2olzx1	55	32	.	.	.
cord-271653-4q2olzx1	56	1	Thus	thus	RB
cord-271653-4q2olzx1	56	2	,	,	,
cord-271653-4q2olzx1	56	3	many	many	JJ
cord-271653-4q2olzx1	56	4	of	of	IN
cord-271653-4q2olzx1	56	5	our	-PRON-	PRP$
cord-271653-4q2olzx1	56	6	patients	patient	NNS
cord-271653-4q2olzx1	56	7	may	may	MD
cord-271653-4q2olzx1	56	8	fall	fall	VB
cord-271653-4q2olzx1	56	9	into	into	IN
cord-271653-4q2olzx1	56	10	the	the	DT
cord-271653-4q2olzx1	56	11	zone	zone	NN
cord-271653-4q2olzx1	56	12	between	between	IN
cord-271653-4q2olzx1	56	13	the	the	DT
cord-271653-4q2olzx1	56	14	two	two	CD
cord-271653-4q2olzx1	56	15	bookends	bookend	NNS
cord-271653-4q2olzx1	56	16	depicted	depict	VBN
cord-271653-4q2olzx1	56	17	in	in	IN
cord-271653-4q2olzx1	56	18	Figure	Figure	NNP
cord-271653-4q2olzx1	56	19	1	1	CD
cord-271653-4q2olzx1	56	20	.	.	.
cord-271653-4q2olzx1	57	1	It	-PRON-	PRP
cord-271653-4q2olzx1	57	2	behooves	behooves	VBP
cord-271653-4q2olzx1	57	3	us	-PRON-	PRP
cord-271653-4q2olzx1	57	4	to	to	TO
cord-271653-4q2olzx1	57	5	consider	consider	VB
cord-271653-4q2olzx1	57	6	the	the	DT
cord-271653-4q2olzx1	57	7	multiple	multiple	JJ
cord-271653-4q2olzx1	57	8	mechanisms	mechanism	NNS
cord-271653-4q2olzx1	57	9	of	of	IN
cord-271653-4q2olzx1	57	10	cardiac	cardiac	JJ
cord-271653-4q2olzx1	57	11	injury	injury	NN
cord-271653-4q2olzx1	57	12	in	in	IN
cord-271653-4q2olzx1	57	13	patients	patient	NNS
cord-271653-4q2olzx1	57	14	with	with	IN
cord-271653-4q2olzx1	57	15	COVID-19	COVID-19	NNP
cord-271653-4q2olzx1	57	16	disease	disease	NN
cord-271653-4q2olzx1	57	17	(	(	-LRB-
cord-271653-4q2olzx1	57	18	Figure	figure	NN
cord-271653-4q2olzx1	57	19	4	4	CD
cord-271653-4q2olzx1	57	20	)	)	-RRB-
cord-271653-4q2olzx1	57	21	.	.	.
cord-271653-4q2olzx1	58	1	As	as	IN
cord-271653-4q2olzx1	58	2	in	in	IN
cord-271653-4q2olzx1	58	3	the	the	DT
cord-271653-4q2olzx1	58	4	BC	BC	NNP
cord-271653-4q2olzx1	58	5	(	(	-LRB-
cord-271653-4q2olzx1	58	6	before	before	IN
cord-271653-4q2olzx1	58	7	COVID	COVID	NNP
cord-271653-4q2olzx1	58	8	)	)	-RRB-
cord-271653-4q2olzx1	58	9	era	era	NN
cord-271653-4q2olzx1	58	10	,	,	,
cord-271653-4q2olzx1	58	11	interpretation	interpretation	NN
cord-271653-4q2olzx1	58	12	of	of	IN
cord-271653-4q2olzx1	58	13	rises	rise	NNS
cord-271653-4q2olzx1	58	14	in	in	IN
cord-271653-4q2olzx1	58	15	cardiac	cardiac	JJ
cord-271653-4q2olzx1	58	16	troponin	troponin	NN
cord-271653-4q2olzx1	58	17	requires	require	VBZ
cord-271653-4q2olzx1	58	18	consideration	consideration	NN
cord-271653-4q2olzx1	58	19	of	of	IN
cord-271653-4q2olzx1	58	20	the	the	DT
cord-271653-4q2olzx1	58	21	context	context	NN
cord-271653-4q2olzx1	58	22	of	of	IN
cord-271653-4q2olzx1	58	23	the	the	DT
cord-271653-4q2olzx1	58	24	clinical	clinical	JJ
cord-271653-4q2olzx1	58	25	situation	situation	NN
cord-271653-4q2olzx1	58	26	.	.	.
cord-271653-4q2olzx1	59	1	Not	not	RB
cord-271653-4q2olzx1	59	2	all	all	DT
cord-271653-4q2olzx1	59	3	rises	rise	VBZ
cord-271653-4q2olzx1	59	4	in	in	IN
cord-271653-4q2olzx1	59	5	this	this	DT
cord-271653-4q2olzx1	59	6	biomarker	biomarker	NN
cord-271653-4q2olzx1	59	7	of	of	IN
cord-271653-4q2olzx1	59	8	cardiac	cardiac	JJ
cord-271653-4q2olzx1	59	9	injury	injury	NN
cord-271653-4q2olzx1	59	10	will	will	MD
cord-271653-4q2olzx1	59	11	result	result	VB
cord-271653-4q2olzx1	59	12	from	from	IN
cord-271653-4q2olzx1	59	13	coronary	coronary	JJ
cord-271653-4q2olzx1	59	14	artery	artery	NN
cord-271653-4q2olzx1	59	15	disease	disease	NN
cord-271653-4q2olzx1	59	16	requiring	require	VBG
cord-271653-4q2olzx1	59	17	invasive	invasive	JJ
cord-271653-4q2olzx1	59	18	assessment	assessment	NN
cord-271653-4q2olzx1	59	19	or	or	CC
cord-271653-4q2olzx1	59	20	intervention	intervention	NN
cord-271653-4q2olzx1	59	21	.	.	.
cord-271653-4q2olzx1	60	1	We	-PRON-	PRP
cord-271653-4q2olzx1	60	2	urgently	urgently	RB
cord-271653-4q2olzx1	60	3	need	need	VBP
cord-271653-4q2olzx1	60	4	randomized	randomized	JJ
cord-271653-4q2olzx1	60	5	clinical	clinical	JJ
cord-271653-4q2olzx1	60	6	trials	trial	NNS
cord-271653-4q2olzx1	60	7	to	to	TO
cord-271653-4q2olzx1	60	8	assess	assess	VB
cord-271653-4q2olzx1	60	9	the	the	DT
cord-271653-4q2olzx1	60	10	value	value	NN
cord-271653-4q2olzx1	60	11	of	of	IN
cord-271653-4q2olzx1	60	12	interventions	intervention	NNS
cord-271653-4q2olzx1	60	13	including	include	VBG
cord-271653-4q2olzx1	60	14	anti	anti	JJ
cord-271653-4q2olzx1	60	15	-	-	JJ
cord-271653-4q2olzx1	60	16	inflammatory	inflammatory	JJ
cord-271653-4q2olzx1	60	17	therapies	therapy	NNS
cord-271653-4q2olzx1	60	18	ranging	range	VBG
cord-271653-4q2olzx1	60	19	from	from	IN
cord-271653-4q2olzx1	60	20	glucocorticoids	glucocorticoid	NNS
cord-271653-4q2olzx1	60	21	to	to	IN
cord-271653-4q2olzx1	60	22	cytokine	cytokine	JJ
cord-271653-4q2olzx1	60	23	antagonism	antagonism	NN
cord-271653-4q2olzx1	60	24	in	in	IN
cord-271653-4q2olzx1	60	25	addition	addition	NN
cord-271653-4q2olzx1	60	26	to	to	IN
cord-271653-4q2olzx1	60	27	antiviral	antiviral	JJ
cord-271653-4q2olzx1	60	28	agents	agent	NNS
cord-271653-4q2olzx1	60	29	as	as	IN
cord-271653-4q2olzx1	60	30	outlined	outline	VBN
cord-271653-4q2olzx1	60	31	in	in	IN
cord-271653-4q2olzx1	60	32	the	the	DT
cord-271653-4q2olzx1	60	33	elegant	elegant	JJ
cord-271653-4q2olzx1	60	34	exposition	exposition	NN
cord-271653-4q2olzx1	60	35	of	of	IN
cord-271653-4q2olzx1	60	36	Atri	Atri	NNP
cord-271653-4q2olzx1	60	37	et	et	FW
cord-271653-4q2olzx1	60	38	al	al	NNP
cord-271653-4q2olzx1	60	39	.	.	.
cord-271653-4q2olzx1	61	1	3	3	LS
cord-271653-4q2olzx1	62	1	Dealing	deal	VBG
cord-271653-4q2olzx1	62	2	with	with	IN
cord-271653-4q2olzx1	62	3	the	the	DT
cord-271653-4q2olzx1	62	4	immense	immense	JJ
cord-271653-4q2olzx1	62	5	challenge	challenge	NN
cord-271653-4q2olzx1	62	6	of	of	IN
cord-271653-4q2olzx1	62	7	COVID-19	COVID-19	NNP
cord-271653-4q2olzx1	62	8	disease	disease	NN
cord-271653-4q2olzx1	62	9	,	,	,
cord-271653-4q2olzx1	62	10	and	and	CC
cord-271653-4q2olzx1	62	11	confronted	confront	VBN
cord-271653-4q2olzx1	62	12	with	with	IN
cord-271653-4q2olzx1	62	13	severely	severely	RB
cord-271653-4q2olzx1	62	14	ill	ill	JJ
cord-271653-4q2olzx1	62	15	patients	patient	NNS
cord-271653-4q2olzx1	62	16	in	in	IN
cord-271653-4q2olzx1	62	17	dire	dire	JJ
cord-271653-4q2olzx1	62	18	straits	strait	NNS
cord-271653-4q2olzx1	62	19	with	with	IN
cord-271653-4q2olzx1	62	20	virtually	virtually	RB
cord-271653-4q2olzx1	62	21	no	no	DT
cord-271653-4q2olzx1	62	22	rigorous	rigorous	JJ
cord-271653-4q2olzx1	62	23	evidence	evidence	NN
cord-271653-4q2olzx1	62	24	base	base	NN
cord-271653-4q2olzx1	62	25	to	to	TO
cord-271653-4q2olzx1	62	26	guide	guide	VB
cord-271653-4q2olzx1	62	27	our	-PRON-	PRP$
cord-271653-4q2olzx1	62	28	therapy	therapy	NN
cord-271653-4q2olzx1	62	29	,	,	,
cord-271653-4q2olzx1	62	30	we	-PRON-	PRP
cord-271653-4q2olzx1	62	31	need	need	VBP
cord-271653-4q2olzx1	62	32	to	to	TO
cord-271653-4q2olzx1	62	33	call	call	VB
cord-271653-4q2olzx1	62	34	upon	upon	IN
cord-271653-4q2olzx1	62	35	our	-PRON-	PRP$
cord-271653-4q2olzx1	62	36	clinical	clinical	JJ
cord-271653-4q2olzx1	62	37	skills	skill	NNS
cord-271653-4q2olzx1	62	38	and	and	CC
cord-271653-4q2olzx1	62	39	judgment	judgment	NN
cord-271653-4q2olzx1	62	40	.	.	.
cord-271653-4q2olzx1	63	1	These	these	DT
cord-271653-4q2olzx1	63	2	touchstones	touchstone	NNS
cord-271653-4q2olzx1	63	3	can	can	MD
cord-271653-4q2olzx1	63	4	help	help	VB
cord-271653-4q2olzx1	63	5	guide	guide	VB
cord-271653-4q2olzx1	63	6	us	-PRON-	PRP
cord-271653-4q2olzx1	63	7	in	in	IN
cord-271653-4q2olzx1	63	8	selecting	select	VBG
cord-271653-4q2olzx1	63	9	patients	patient	NNS
cord-271653-4q2olzx1	63	10	who	who	WP
cord-271653-4q2olzx1	63	11	might	may	MD
cord-271653-4q2olzx1	63	12	benefit	benefit	VB
cord-271653-4q2olzx1	63	13	from	from	IN
cord-271653-4q2olzx1	63	14	the	the	DT
cord-271653-4q2olzx1	63	15	advanced	advanced	JJ
cord-271653-4q2olzx1	63	16	imaging	imaging	NN
cord-271653-4q2olzx1	63	17	and	and	CC
cord-271653-4q2olzx1	63	18	invasive	invasive	JJ
cord-271653-4q2olzx1	63	19	procedures	procedure	NNS
cord-271653-4q2olzx1	63	20	that	that	WDT
cord-271653-4q2olzx1	63	21	present	present	VBP
cord-271653-4q2olzx1	63	22	enormous	enormous	JJ
cord-271653-4q2olzx1	63	23	logistical	logistical	JJ
cord-271653-4q2olzx1	63	24	challenges	challenge	NNS
cord-271653-4q2olzx1	63	25	in	in	IN
cord-271653-4q2olzx1	63	26	the	the	DT
cord-271653-4q2olzx1	63	27	current	current	JJ
cord-271653-4q2olzx1	63	28	context	context	NN
cord-271653-4q2olzx1	63	29	.	.	.
cord-271653-4q2olzx1	64	1	In	in	IN
cord-271653-4q2olzx1	64	2	the	the	DT
cord-271653-4q2olzx1	64	3	absence	absence	NN
cord-271653-4q2olzx1	64	4	of	of	IN
cord-271653-4q2olzx1	64	5	a	a	DT
cord-271653-4q2olzx1	64	6	robust	robust	JJ
cord-271653-4q2olzx1	64	7	evidence	evidence	NN
cord-271653-4q2olzx1	64	8	base	base	NN
cord-271653-4q2olzx1	64	9	,	,	,
cord-271653-4q2olzx1	64	10	we	-PRON-	PRP
cord-271653-4q2olzx1	64	11	will	will	MD
cord-271653-4q2olzx1	64	12	also	also	RB
cord-271653-4q2olzx1	64	13	need	need	VB
cord-271653-4q2olzx1	64	14	to	to	TO
cord-271653-4q2olzx1	64	15	invoke	invoke	VB
cord-271653-4q2olzx1	64	16	pathophysiologic	pathophysiologic	JJ
cord-271653-4q2olzx1	64	17	reasoning	reason	VBG
cord-271653-4q2olzx1	64	18	to	to	TO
cord-271653-4q2olzx1	64	19	guide	guide	VB
cord-271653-4q2olzx1	64	20	our	-PRON-	PRP$
cord-271653-4q2olzx1	64	21	choices	choice	NNS
cord-271653-4q2olzx1	64	22	of	of	IN
cord-271653-4q2olzx1	64	23	therapy	therapy	NN
cord-271653-4q2olzx1	64	24	for	for	IN
cord-271653-4q2olzx1	64	25	each	each	DT
cord-271653-4q2olzx1	64	26	individual	individual	JJ
cord-271653-4q2olzx1	64	27	clinical	clinical	JJ
cord-271653-4q2olzx1	64	28	scenario	scenario	NN
cord-271653-4q2olzx1	64	29	.	.	.
cord-271653-4q2olzx1	65	1	We	-PRON-	PRP
cord-271653-4q2olzx1	65	2	must	must	MD
cord-271653-4q2olzx1	65	3	do	do	VB
cord-271653-4q2olzx1	65	4	so	so	RB
cord-271653-4q2olzx1	65	5	with	with	IN
cord-271653-4q2olzx1	65	6	caution	caution	NN
cord-271653-4q2olzx1	65	7	and	and	CC
cord-271653-4q2olzx1	65	8	extreme	extreme	JJ
cord-271653-4q2olzx1	65	9	humility	humility	NN
cord-271653-4q2olzx1	65	10	,	,	,
cord-271653-4q2olzx1	65	11	recognizing	recognize	VBG
cord-271653-4q2olzx1	65	12	how	how	WRB
cord-271653-4q2olzx1	65	13	often	often	RB
cord-271653-4q2olzx1	65	14	plausible	plausible	JJ
cord-271653-4q2olzx1	65	15	interventions	intervention	NNS
cord-271653-4q2olzx1	65	16	fail	fail	VBP
cord-271653-4q2olzx1	65	17	when	when	WRB
cord-271653-4q2olzx1	65	18	tested	test	VBN
cord-271653-4q2olzx1	65	19	rigorously	rigorously	RB
cord-271653-4q2olzx1	65	20	.	.	.
cord-271653-4q2olzx1	66	1	But	but	CC
cord-271653-4q2olzx1	66	2	act	act	VB
cord-271653-4q2olzx1	66	3	today	today	NN
cord-271653-4q2olzx1	66	4	we	-PRON-	PRP
cord-271653-4q2olzx1	66	5	must	must	MD
cord-271653-4q2olzx1	66	6	,	,	,
cord-271653-4q2olzx1	66	7	and	and	CC
cord-271653-4q2olzx1	66	8	the	the	DT
cord-271653-4q2olzx1	66	9	overview	overview	NN
cord-271653-4q2olzx1	66	10	of	of	IN
cord-271653-4q2olzx1	66	11	Atri	Atri	NNP
cord-271653-4q2olzx1	66	12	et	et	FW
cord-271653-4q2olzx1	66	13	al	al	NNP
cord-271653-4q2olzx1	66	14	.	.	.
cord-271653-4q2olzx1	66	15	and	and	CC
cord-271653-4q2olzx1	66	16	other	other	JJ
cord-271653-4q2olzx1	66	17	recent	recent	JJ
cord-271653-4q2olzx1	66	18	compendia	compendia	NNS
cord-271653-4q2olzx1	66	19	will	will	MD
cord-271653-4q2olzx1	66	20	help	help	VB
cord-271653-4q2olzx1	66	21	us	-PRON-	PRP
cord-271653-4q2olzx1	66	22	meet	meet	VB
cord-271653-4q2olzx1	66	23	our	-PRON-	PRP$
cord-271653-4q2olzx1	66	24	mission	mission	NN
cord-271653-4q2olzx1	66	25	unsupported	unsupported	JJ
cord-271653-4q2olzx1	66	26	by	by	IN
cord-271653-4q2olzx1	66	27	the	the	DT
cord-271653-4q2olzx1	66	28	comfort	comfort	NN
cord-271653-4q2olzx1	66	29	of	of	IN
cord-271653-4q2olzx1	66	30	strong	strong	JJ
cord-271653-4q2olzx1	66	31	data	datum	NNS
cord-271653-4q2olzx1	66	32	.	.	.
cord-271653-4q2olzx1	67	1	3	3	CD
cord-271653-4q2olzx1	67	2	 	 	_SP
cord-271653-4q2olzx1	68	1	Coronavirus	Coronavirus	NNP
cord-271653-4q2olzx1	68	2	fulminant	fulminant	JJ
cord-271653-4q2olzx1	68	3	myocarditis	myocarditis	NN
cord-271653-4q2olzx1	68	4	treated	treat	VBN
cord-271653-4q2olzx1	68	5	with	with	IN
cord-271653-4q2olzx1	68	6	glucocorticoid	glucocorticoid	NN
cord-271653-4q2olzx1	68	7	and	and	CC
cord-271653-4q2olzx1	68	8	human	human	JJ
cord-271653-4q2olzx1	68	9	immunoglobulin	immunoglobulin	NN
cord-271653-4q2olzx1	68	10	Cardiac	Cardiac	NNP
cord-271653-4q2olzx1	68	11	Involvement	Involvement	NNP
cord-271653-4q2olzx1	68	12	in	in	IN
cord-271653-4q2olzx1	68	13	a	a	DT
cord-271653-4q2olzx1	68	14	Patient	patient	NN
cord-271653-4q2olzx1	68	15	With	with	IN
cord-271653-4q2olzx1	68	16	Coronavirus	Coronavirus	NNP
cord-271653-4q2olzx1	68	17	Disease	Disease	NNP
cord-271653-4q2olzx1	68	18	2019	2019	CD
cord-271653-4q2olzx1	68	19	(	(	-LRB-
cord-271653-4q2olzx1	68	20	COVID-19	COVID-19	NNP
cord-271653-4q2olzx1	68	21	)	)	-RRB-
cord-271653-4q2olzx1	68	22	COVID-19	COVID-19	VBD
cord-271653-4q2olzx1	68	23	for	for	IN
cord-271653-4q2olzx1	68	24	the	the	DT
cord-271653-4q2olzx1	68	25	Cardiologist	Cardiologist	NNP
cord-271653-4q2olzx1	68	26	:	:	:
cord-271653-4q2olzx1	68	27	A	a	DT
cord-271653-4q2olzx1	68	28	State	state	NN
cord-271653-4q2olzx1	68	29	-	-	HYPH
cord-271653-4q2olzx1	68	30	of	of	IN
cord-271653-4q2olzx1	68	31	-	-	HYPH
cord-271653-4q2olzx1	68	32	the	the	DT
cord-271653-4q2olzx1	68	33	-	-	HYPH
cord-271653-4q2olzx1	68	34	Art	Art	NNP
cord-271653-4q2olzx1	68	35	Review	Review	NNP
cord-271653-4q2olzx1	68	36	of	of	IN
cord-271653-4q2olzx1	68	37	the	the	DT
cord-271653-4q2olzx1	68	38	Virology	Virology	NNP
cord-271653-4q2olzx1	68	39	,	,	,
cord-271653-4q2olzx1	68	40	Clinical	Clinical	NNP
cord-271653-4q2olzx1	68	41	Epidemiology	Epidemiology	NNP
cord-271653-4q2olzx1	68	42	,	,	,
cord-271653-4q2olzx1	68	43	Cardiac	Cardiac	NNP
cord-271653-4q2olzx1	68	44	and	and	CC
cord-271653-4q2olzx1	68	45	Other	Other	NNP
cord-271653-4q2olzx1	68	46	Clinical	Clinical	NNP
cord-271653-4q2olzx1	68	47	Manifestations	Manifestations	NNPS
cord-271653-4q2olzx1	68	48	and	and	CC
cord-271653-4q2olzx1	68	49	Potential	potential	JJ
cord-271653-4q2olzx1	68	50	Therapeutic	therapeutic	JJ
cord-271653-4q2olzx1	68	51	Strategies	strategy	NNS
cord-271653-4q2olzx1	68	52	.	.	.
cord-271653-4q2olzx1	69	1	JACC	JACC	NNP
cord-271653-4q2olzx1	69	2	:	:	:
cord-271653-4q2olzx1	70	1	Basic	basic	JJ
cord-271653-4q2olzx1	70	2	to	to	IN
cord-271653-4q2olzx1	70	3	Translational	Translational	NNP
cord-271653-4q2olzx1	70	4	Science	Science	NNP
cord-271653-4q2olzx1	70	5	Roles	Roles	NNPS
cord-271653-4q2olzx1	70	6	of	of	IN
cord-271653-4q2olzx1	70	7	infectious	infectious	JJ
cord-271653-4q2olzx1	70	8	agents	agent	NNS
cord-271653-4q2olzx1	70	9	in	in	IN
cord-271653-4q2olzx1	70	10	atherosclerosis	atherosclerosis	NN
cord-271653-4q2olzx1	70	11	and	and	CC
cord-271653-4q2olzx1	70	12	restenosis	restenosis	NN
cord-271653-4q2olzx1	70	13	:	:	:
cord-271653-4q2olzx1	70	14	an	an	DT
cord-271653-4q2olzx1	70	15	assessment	assessment	NN
cord-271653-4q2olzx1	70	16	of	of	IN
cord-271653-4q2olzx1	70	17	the	the	DT
cord-271653-4q2olzx1	70	18	evidence	evidence	NN
cord-271653-4q2olzx1	70	19	and	and	CC
cord-271653-4q2olzx1	70	20	need	need	NN
cord-271653-4q2olzx1	70	21	for	for	IN
cord-271653-4q2olzx1	70	22	future	future	JJ
cord-271653-4q2olzx1	70	23	research	research	NN
cord-271653-4q2olzx1	70	24	Inflammation	inflammation	NN
cord-271653-4q2olzx1	70	25	,	,	,
cord-271653-4q2olzx1	70	26	Immunity	Immunity	NNP
cord-271653-4q2olzx1	70	27	,	,	,
cord-271653-4q2olzx1	70	28	and	and	CC
cord-271653-4q2olzx1	70	29	Infection	infection	NN
cord-271653-4q2olzx1	70	30	in	in	IN
cord-271653-4q2olzx1	70	31	Atherothrombosis	Atherothrombosis	NNP
cord-271653-4q2olzx1	70	32	:	:	:
cord-271653-4q2olzx1	71	1	JACC	JACC	NNP
cord-271653-4q2olzx1	71	2	Review	Review	NNP
cord-271653-4q2olzx1	71	3	Topic	Topic	NNP
cord-271653-4q2olzx1	71	4	of	of	IN
cord-271653-4q2olzx1	71	5	the	the	DT
cord-271653-4q2olzx1	71	6	Week	Week	NNP
cord-271653-4q2olzx1	71	7	Leukocytes	Leukocytes	NNPS
cord-271653-4q2olzx1	71	8	Link	Link	NNP
cord-271653-4q2olzx1	71	9	Local	local	JJ
cord-271653-4q2olzx1	71	10	and	and	CC
cord-271653-4q2olzx1	71	11	Systemic	systemic	JJ
cord-271653-4q2olzx1	71	12	Inflammation	inflammation	NN
cord-271653-4q2olzx1	71	13	in	in	IN
cord-271653-4q2olzx1	71	14	Ischemic	Ischemic	NNP
cord-271653-4q2olzx1	71	15	Cardiovascular	Cardiovascular	NNP
cord-271653-4q2olzx1	71	16	Disease	Disease	NNP